WO2008118670A2 - Devices and methods for controlling expandable prostheses during deployment - Google Patents
Devices and methods for controlling expandable prostheses during deployment Download PDFInfo
- Publication number
- WO2008118670A2 WO2008118670A2 PCT/US2008/057202 US2008057202W WO2008118670A2 WO 2008118670 A2 WO2008118670 A2 WO 2008118670A2 US 2008057202 W US2008057202 W US 2008057202W WO 2008118670 A2 WO2008118670 A2 WO 2008118670A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prosthesis
- prostheses
- catheter
- sheath
- self
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9517—Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/826—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91591—Locking connectors, e.g. using male-female connections
Definitions
- This invention relates generally to medical apparatus and methods, and more specifically to vascular catheters, stents and stent delivery systems for use in the coronary and peripheral arteries as well as other vessels and body lumens.
- Stenting is an important treatment option for patients with occlusive disease in the vasculature as well as other systems such as the biliary tract.
- the stenting procedure involves placing a tubular prosthesis at the site of a lesion, typically within a diseased artery. The procedure is performed in order to maintain the patency of the artery and is often performed after a primary treatment such as angioplasty.
- a primary treatment such as angioplasty.
- stent results suffered from high rates of restenosis i.e. the tendency for the stented vessel, such as an artery, to become re-occluded following stent implantation.
- restenosis rates have decreased substantially, due to many improvements in stent delivery, stent technology as well as the use of drugs. As a result, the number of stent related procedures being performed worldwide continues to dramatically increase.
- Stents are typically either self-expanding or balloon expandable and they are delivered to the arteries using long, flexible vascular catheters typically inserted percutaneously through the patient's femoral artery.
- balloon expandable stents the stents are usually mounted over a balloon on the delivery catheter, thus, when the balloon is inflated, it expands which correspondingly expands and deforms the stent to the desired diameter. The balloon can then be deflated and removed, leaving the stent in place.
- self- expanding stents the stent is released from the delivery catheter and it resiliency expands into engagement with the vessel wall.
- Self-expanding stents are often used in the peripheral vascular system since they are more resilient than balloon expandable stents. Resilient stents are better suited for implantation into regions of the body closer to the body's surface, such as a peripheral artery, since the stent's resilience helps minimize damage or crashing caused by body movement or externally applied forces. [0004] Self-expanding stents may also be used in the coronary arteries and may provide advantages over balloon expandable stents. Balloon expandable stents are typically expanded with a balloon having a constant diameter and therefore the expanded stent may not conform well to a coronary artery having variations in diameter due to tortuosity or taper.
- a single long stent may be deployed to treat a single lesion or to span multiple lesions, however this is not optimal since longer stents tend to have higher fracture and restenosis rates as compared with shorter stents. Therefore, placement of multiple shorter stents in a long lesion may be advantageous instead of deploying a single long length stent.
- 021629-003600US entitled “Apparatus and Methods for Deployment of Linked Prosthetic Segments”
- serial number 11/469,773 filed September 1 , 2006
- serial number 11/462,951, filed August 7, 2006 entitled “Custom Length Stent Apparatus.”
- the full disclosures of each of these patents and applications are incorporated herein by reference.
- the invention generally provides for the delivery of self-expanding prostheses with a flexible delivery catheter capable of navigating vessels such as the peripheral and coronary arteries.
- the delivery catheter permits controlled deployment of a selectable number of prosthetic segments at a treatment site, thus allowing customization of prosthesis length while the delivery catheter is in a body lumen at a treatment site. Customization of prosthesis length in situ permits better matching of the prosthesis length to the lesion length being treated.
- the terms “stent” and “stenting” are defined to include any of the array of expandable prostheses and scaffolds which are introduced into a lumen at a target treatment site and expanded in situ thereby exerting a radially outward force against the lumen wall.
- the prosthesis of the present invention comprises a closed or an open lattice structure and is typically fabricated from an elastic material or self-expanding material, including superelastic materials such as nickel-titanium alloys like Nitinol, or spring temper stainless steels or polymers, and the lattice structures are commonly constrained radially during delivery and upon deployment the constraining structure is removed, allowing the prosthesis to "self- expand” at the target site.
- the terms “stent,” “prosthesis,” “prosthetic segment” and “stent segment” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within a body lumen.
- a catheter for delivering a prosthesis to a treatment site in a body lumen comprises an elongate flexible member having a proximal end and a distal end.
- a sheath is slidably disposed over the elongate flexible member and a plurality of self-expanding tubular prostheses are carried in axially spaced-apart locations along the elongate flexible member, within the sheath.
- the plurality of self-expanding tubular prostheses are adapted to be selectively interlocked with one another and they are constrained by the sheath in a radially contracted configuration.
- the prostheses are separately releasable from the sheath as the sheath is retracted relative to the elongate flexible member.
- the catheter also includes a pusher member that is slidably disposed along the elongate flexible member within the sheath and the pusher is adapted to move past the prostheses in a first direction, usually without displacing the prostheses. In a second direction, the pusher member engages a selected prosthesis and the pusher can move the prosthesis so as to interlock the selected prosthesis with a second prosthesis.
- the pusher member may have an engagement member which is deflectable radially inward by contact with the prostheses when moved in the first direction while in the second direction the engagement member engages the prostheses selected for deployment.
- the engagement member may comprise a plurality of flexible fingers that extend radially outward from the pusher member. The pusher member often may exert substantially greater axial force against the plurality of self-expanding tubular prostheses when the pusher member is advanced distally than when the pusher member is retracted proximally.
- the catheter comprises a stopping element that is axially disposed along the elongate flexible member.
- the stopping element is adapted to prevent the plurality of self-expanding tubular prostheses from being displaced past the distal end of the elongate flexible member when the pusher member is advanced distally.
- the catheter may also comprise a handle that is usually near the proximal end of the elongate flexible member and the handle usually has a control mechanism adapted to move the sheath and pusher member.
- the catheter may also include a central lumen disposed within the elongate shaft that can carry a guidewire.
- a method for delivering a prosthesis to a body lumen having a lesion with a length comprises introducing into the body lumen one or more self-expanding tubular prostheses.
- the prostheses are carried at axially spaced apart locations along an elongate flexible member and they are constrained in a contracted configuration within a sheath.
- Selecting a first group of the tubular prostheses for delivery picks a first group of prostheses that has a combined length substantially traversing the lesion.
- the method may further comprise selecting one or more additional self-expanding tubular prostheses and bringing them into to engagement with the first group within the sheath so that the additional prostheses interlock with the first group.
- Selecting a first group of prostheses may comprise proximally retracting a pusher member.
- the pusher member often has a flexible engagement member that is deflected by the prostheses as the pusher member is retracted proximally.
- Bringing the first group into engagement with each other may comprise engaging at least one of the first group of prostheses with a pusher member and advancing the pusher member distally.
- Bringing the first group into engagement with each other may also comprise stopping the first group of prostheses from moving distally with a stopping element that is disposed on the elongate flexible member.
- Engaging the at least one prosthesis may include engaging the prosthesis with a flexible engagement member that is disposed on the pusher member and uncovering the first group can involve proximally retracting the sheath.
- the method may also comprise
- the therapeutic agent may comprise an anti-restenosis agent.
- a self-expanding tubular prosthesis comprises a plurality of self-expanding tubular rings that have a plurality of axial struts and a plurality of connectors coupling adjacent struts together.
- the axial struts and connectors also may form a plurality of substantially parallel and spaced apart columns of open cells.
- the axial struts and connectors often form a substantially zig-zag pattern and a bridge member couples adjacent tubular rings together.
- a plurality of bridges, which may be sigmoidally shaped may join the columns of open cells or rings together.
- the connectors are U-shaped and often the columns of open cells are out of phase with an adjacent column.
- the prosthesis is usually adapted to be interlocked with an adjacent prosthesis when pressed together and the prostheses remain interlocked with one another even after radial self- expansion.
- the prosthesis often may have an interlocking tab on one end of the tubular rings that is adapted to interlock with an adjacent tubular ring when the rings are pressed together.
- the interlocking tab may comprise a strut that defines an aperture which is adapted to hold a radiopaque marker.
- the bridge may be coupled to a connector and have an axially extending strut that joins the bridge with the connector.
- the bridge may connect to an apex of the connector, which may be U-shaped.
- the interlocking tab may comprise a narrow neck region and an enlarged head region which may be C-shaped.
- the enlarged head region may have an arcuate strut defining a narrow inlet portion and a wider receiving portion.
- the receiving portion is usually adapted to receive and interlock with an interlocking tab on an adjacent ring.
- the enlarged head region may have a plurality of arcuate struts that are coupled to the ring with a plurality of axial struts and the neck region may comprise a plurality of axial struts.
- the enlarged head region may also comprise an arcuate strut that forms a C-shape and that is coupled to the ring with an axial strut.
- the prosthesis may also have a female receiving tab on an end of the prosthesis opposite of the interlocking tab.
- the female tab may include an arcuate strut that defines a receptacle, sometimes C-shaped, which can receive and interlock with an enlarged head of an adjacent prosthesis.
- the arcuate strut may be coupled to a ring with an axial strut.
- the female tab may also comprise an arcuate strut that defines an aperture which can hold a radiopaque marker.
- the prosthesis may further comprise a therapeutic agent that is carried on the prosthesis and that may be released therefrom. Often, the therapeutic agent comprises an anti-restenosis agent.
- the prosthesis often has an overall length in the range from about 5 mm to about 50 mm. Sometimes each of the prostheses have the same length, although sometimes at least one of the prostheses may have a different length than another of the prostheses.
- FIG. 1 A is a perspective view of an over-the-wire stent delivery catheter in accordance with one embodiment of the present invention.
- Fig. IB is a cross section of the distal end of the stent delivery catheter illustrated in Fig. IA.
- FIG. 1 C is a perspective view of a stent delivery catheter in accordance with another embodiment of the present invention.
- Figs. 2A-2E illustrate selection and deployment of prostheses in accordance with an exemplary embodiment.
- Fig. 3 A shows a top view of a prosthesis after it has been unrolled and flattened.
- Fig. 3B shows interlocking of two of the prostheses illustrated in Fig. 3A.
- Fig. 3C shows interlocking of two of the prostheses illustrated in Fig. 3 A after expansion.
- Fig. 3D highlights the interlocking of prostheses shown in Fig. 3C.
- Fig. 4A shows a top view of another embodiment of a prosthesis after it has been unrolled and flattened.
- Fig. 4B shows interlocking of two of the prostheses illustrated in Fig. 4A.
- FIG. 5 A shows a top view of still another embodiment of a prosthesis after it has been unrolled and flattened.
- Fig. 5B shows interlocking of two of the prostheses illustrated in Fig. 5 A.
- an over-the-wire prosthesis delivery catheter 50 comprises a catheter shaft 120 which includes a sheath 124 slidably disposed over a pusher tube 144 which is in turn slidably disposed over an inner shaft 134 (seen in Fig. IB).
- a prosthesis 126 is carried near the distal end of the catheter shaft 120 and is covered by sheath 124.
- Pusher tube 144 is adapted to move past the prosthesis 126 in one direction and to push prosthesis 126 in a second direction and this will be described in greater detail below.
- Prosthesis 126 preferably comprises a plurality of self-expanding prostheses 128 mounted under sheath 124 and disposed over inner shaft 134. Sheath 124 covers the self-expanding prostheses 128 and constrains them in a radially contracted configuration until the delivery catheter 50 has been properly positioned at a treatment site.
- a radiopaque marker 152 (Fig.
- Radiopaque marker 153 also helps the operator to view the distance the pusher 144 has been retracted relative to the radiopaque marker 152 adjacent to nosecone 136. This helps the operator determine how many prostheses 128 to deploy and will be discussed in greater detail below.
- handle 106 is attached to a proximal end 112 of the outer sheath 124.
- the handle 106 performs several functions, including retracting and advancing outer sheath 124 and pusher tube 144 thereby allowing selection and exposure of prosthetic segments 128 so that they may self-expand and be deployed.
- a guidewire 138 is positioned slidably through adapter 108 of handle 106 and extends through inner lumen 135, exiting distal port 156.
- Handle 106 includes a housing 110 which encloses the internal components of the handle 106. Handle 106 allows a physician operator to advance or retract outer sheath 124 and pusher tube 144. The amount of retraction of sheath 124 and pusher tube 144 determine the number of individual prostheses 128 to be deployed thereby establishing the overall length of the prosthesis 126 while ensuring accurate delivery of the individual prostheses 128.
- the inner shaft 134 is preferably fixed to the handle housing 110, while both outer sheath 124 and pusher tube 144 are coupled to slide mechanisms 102 and 140, respectively. Slide mechanisms 102 and 140 allow both the outer sheath 124 and pusher tube 144 to be retracted and advanced relative to handle 106.
- a single slide mechanism could be used to control motion of the outer sheath 124 and pusher tube 144.
- Other handle embodiments are described in U.S. Patent Application No. 11/614,271 (Attorney Docket No. 021629- 00221 OUS), the entire contents of which are hereby incorporated by reference.
- the slide mechanism 102 translates along calibrated slot 104.
- Slide mechanism 102 is coupled with outer sheath 124.
- Slide mechanism 102 is adapted to retract the outer sheath 124 a selected distance so that the self-expanding tubular prostheses 128 may be exposed for delivery. As sheath 124 is retracted, the distal most section of prosthesis 128 begins to expand. Additional details on the operation of sheath 124 and pusher 144 are described below.
- the slide mechanism 102 may include optional visual markers 148 that allow an operator to easily determine the length or number of prostheses that have been exposed.
- slide mechanism 102 may have detents or a ratchet that provides audible or tactile feedback to the operator to facilitate operation of the stent delivery catheter 50 without requiring direct visualization during operation.
- Handle 106 also comprises a second control mechanism 140 that translates along calibrated slot 142. Slide mechanism 140 is coupled with the pusher tube 144 and is adapted to retract or advance pusher tube 144 independently of outer sheath 124. Retracting pusher tube 144 allows the number of prostheses 128 to be selected for deployment. Advancement of pusher tube 144 advances the prostheses 128 distally and couples the prostheses 128 together.
- Slide mechanism 140 may also include optional visual markers 150 that help the physician determine the position of the pusher tube 144 or the number of prostheses 128 selected for deployment or the total length thereof. Additionally, the slide mechanism 140 may comprise detents or a ratchet that further assists physician operation by providing audible or tactile feedback. Further details on operation of the pusher tube 144 and the outer sheath 124 are discussed below.
- Handle 106 also permits connection of an external fluid source via adapter 108 attached to the proximal end of handle 106. Fluid may then be injected at the proximal handle end and infused along a lumen in inner shaft 134 into a patient via distal port 156 or other infusion ports (not shown) near the distal end of the delivery catheter 50.
- the adaptor 108 preferably a Luer connector, is configured to be fiuidly coupled with a fluid source such as a syringe or intravenous bag.
- adaptor 108 may be fluidly connected to an inflation lumen 135 in inner shaft 134 which is connected to an optional inflatable balloon (not shown) near the distal end of the catheter 50.
- An inflation device which may be any commercially available balloon inflation device such as those sold under the trade name "IndeflatorTM," manufactured by Abbott (formerly Guidant Corporation of Santa Clara, CA) may then be connected to adaptor 108 to deliver an inflation fluid to the balloon.
- Outer sheath 124 may be composed of any of a variety of biocompatible materials, such as but not limited to a polymer like PTFE, FEP, polyimide, Nylon or Pebax, and may be reinforced with a metallic or polymeric braid to resist radial expansion of self-expanding prostheses 128. Similar materials may also be used for the inner shaft 134. Both the inner shaft 134 and outer sheath 124 may also be fabricated from metals such stainless steel or nickel-titanium alloys like nitinol.
- Pusher tube 144 is seen in Fig. IB.
- Pusher tube 144 is an elongate tube having a central lumen that is slidably disposed over inner shaft 134 and under outer sheath 124.
- the proximal end of pusher tube 144 is coupled with handle 106 as discussed above.
- the distal end of pusher 144 is adapted to slide under prostheses 128 when pusher 144 is retracted and to engage a prosthesis 128 and move it distally when pusher 144 is advanced distally.
- the pusher 144 therefore selects the number of prostheses 128 for delivery and provides enough force to interlock prostheses 128 together as will be discussed below.
- Pusher tube 144 is often an extruded polymer tube, manufactured from similar materials as the outer sheath 124 or inner shaft 134.
- the distal tip of pusher 144 typically comprises resilient fingers 166 which may be a polymer or a metal ring with resilient fingers 166 formed from metals such as spring temper stainless steel or nickel-titanium alloy such as nitinol bonded or welded to the distal end of pusher 144.
- Pusher tube 144 may also be made from nitinol tubing with resilient fingers on the distal end.
- Fig. 1 C illustrates another embodiment of a prosthesis delivery catheter 100 similar to delivery catheter 50 described in Fig. IA, except that delivery catheter 100 now comprises a guidewire tube and is not a simple over the wire catheter.
- Delivery catheter 100 comprises a catheter shaft 120 which includes a sheath 124 slidably disposed over a pusher tube 144 which is in turn slidably disposed over an inner shaft 134 (seen in Fig. 2A).
- a prosthesis 126 is carried near the distal end of the catheter shaft 120 and is covered by sheath 124.
- Pusher tube 144 is adapted to move past the prosthesis 126 in one direction and to push prosthesis 126 in a second direction as described further below.
- Prosthesis 126 preferably comprises a plurality of self-expanding prostheses 128 mounted under sheath 124 and disposed over inner shaft 134. Sheath 124 covers the self-expanding prostheses 128 and constrains them in a radially contracted configuration until the delivery catheter 100 has been properly positioned at a treatment site.
- a radiopaque marker 152 (Fig.
- Radiopaque marker 153 also helps the operator to view the distance the pusher 144 has been retracted relative to the radiopaque marker 152 adjacent to nosecone 136. This helps the operator determine how many prostheses 128 to deploy and will be discussed in greater detail below.
- a guidewire tube 122 is slidably positioned through sheath 124 and inner shaft 134 proximal to the prosthesis 126.
- a guidewire 138 is positioned slidably through guidewire tube 122 and nosecone 136 and exits a distal exit port 156, extending distally thereof. Additional details on guidewire tube 122 are disclosed in copending U.S. Patent Application No. 10/814,581 (Attorney Docket No. 021629-001000US), the entire contents of which are hereby incorporated by reference.
- a handle 106 is attached to a proximal end 112 of the outer sheath 124.
- the handle 106 generally takes the same form as handle 106 which was previously described above with reference to Fig. IA and controls the movement of outer sheath 124 and pusher tube 144.
- Fig. 1C shows two sliders 102, 140 used to control sheath 124 and pusher 144, however, optionally, a single slide mechanism could be used to control motion of the outer sheath 124 and pusher tube 144.
- Other handle embodiments are described in U.S. Patent Application No. 11/614,271 (Attorney Docket No.
- Both outer sheath 124 and guidewire 138 each extend through a slider assembly 132 slidaby disposed on the catheter body 120 at a point between its handle 106 and prostheses 128.
- the slider assembly 132 is adapted for insertion into and sealing with a hemostasis valve, such as on an introducer sheath or guiding catheter, while still allowing relative movement of the outer sheath 124 relative to the slider assembly 132.
- the slider assembly 132 includes a slider tube 118, a slider body 116, and a slider cap 1 14.
- Outer sheath 124 may be composed of any of a variety of biocompatible materials, such as but not limited to a polymer like PTFE, FEP, polyimide, Nylon or Pebax, and may be reinforced with a metallic or polymeric braid to resist radial expansion of self-expanding prostheses 128. Similar materials may also be used for the inner shaft 134. Both the inner shaft 134 and outer sheath 124 may also be fabricated from metals such as stainless steel or nickel-titanium alloys like nitinol.
- Pusher tube 144 is seen in Fig. 2A.
- Pusher tube 144 generally takes the same form as pusher 144 in Fig. IB and is an elongate tube having a central lumen that is slidably disposed over inner shaft 134 and under outer sheath 124.
- the proximal end of pusher tube 144 is coupled with handle 106 as discussed above.
- the distal end of pusher 144 is adapted to slide under prostheses 128 when pusher 144 is retracted and to engage a prosthesis 128 and move it distally when pusher 144 is advanced distally.
- the pusher 144 therefore selects the number of prostheses 128 for delivery and provides enough force to interlock prostheses 128 together as will be discussed below.
- Pusher tube 144 may be fabricated similarly as previously described.
- Prosthesis 126 in Figs. 1 A-IC is composed of one or more prostheses 128.
- Prostheses 128 are disposed over the inner shaft 134 and under sheath 124.
- Each prosthesis or segment 128 has interlocking tabs on each end and is about 3-50 mm in length, more typically about 10-30 mm in length and preferably being about 15-25 mm in length.
- Usually 2-20, more typically 2-15 and preferably 5-10 prostheses 128 are positioned axially over the inner shaft 134.
- Prostheses 128 are preferably positioned with a spacing in between prostheses 128. The spacing is typically between about 0.5 mm and about 1 mm.
- prostheses 128 selected for deployment are pressed together so that interlocking tabs engage and the prostheses 128 are coupled together.
- prostheses 128 may be deployed individually or in groups of two or more at a single treatment site within the vessel lumen.
- the adjacent ends have axially extending members that interleave and engage with one another.
- the geometry of prosthesis 300 is illustrated in an unexpanded configuration, unrolled and flattened out for clarity.
- prosthesis 300 comprises eleven substantially parallel columns 302a,
- Each column 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k is formed from an undulating or sinusoidal or zig-zag or wave pattern 318.
- the wave pattern 318 is comprised of substantially axial struts 320 joined together by a U-shaped connector 322.
- the struts 320 are generally parallel to the central axis 324.
- each wave pattern 318 repeats itself sixteen times in each of the eleven parallel columns 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326, although this number is not intended to be limiting.
- the number of rows of cells may be increased to provide increased scaffolding of the lumen wall or the number of rows may be decreased to minimize the amount of metal in the prosthesis which contacts the lumen wall.
- the wave pattern 318 in each column is out-of-phase with the adjacent column, therefore the peak of one wave pattern 318 is adjacent to the trough of a wave 318 pattern in an adjacent column.
- the parallel columns 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326 are joined together by a sigmoidal shaped connector 328 which joins the ends of U-shaped connector 322 together.
- the sigmoidal connector 328 generally attaches to the apex of the U-shaped connector 322.
- the sigmoidal shaped connector 328 attaches generally to every fourth U-shaped connector 322, in each column 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k, thus there are four sigmoidal shaped connectors 328 between each column 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326.
- the slope of the sigmoidal shaped connectors 328 generally slopes downward between columns 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326.
- the sigmoidal shaped connector 328 between column 302a and 302b is attached to U-shaped connector 322 in column 302a at a point generally at the apex of the U-shaped connector 322 and substantially parallel to the axial struts 320.
- the sigmoidal connector 328 slopes downward toward the adjacent U-shaped connector 322 in adjacent column 302b and attaches to the adjacent U-shaped connector 322 at a point generally at the apex of U-shaped connector 322 and substantially parallel to the axial struts 320.
- the sigmoidal shaped connector 322 between columns 302b and 302c similarly joins U-shaped connectors 322, sloping downward. This pattern repeats across the prosthesis 300 so that there are ten sets of sigmoidal shaped connectors 328 with downward slopes.
- sigmoidal shaped connectors 322 are staggered such that across any row of open cells 326, a sigmoidal shaped connector 322 couples columns of open cells 326 every fourth gap 330.
- Both ends of prosthesis 300 also comprise locking tabs 332 having a narrow neck portion 333 and a wider head portion 335 defined by curved strut 338.
- Each locking tab 332 is joined to the body of the prosthesis 300 by an axial strut 340 which join to every fourth U- shaped connector 322 at its apex.
- Strut 338 defines a U-shape or C-shape with enlarged and rounded tips 337 that define a receptacle 339 therein.
- the receptacle 339 may be fitted with an optional radiopaque marker 341 to enhance visibility of the prosthesis under a fluoroscope.
- a space 342 is disposed between ends of locking tabs 332, defined by a narrow inlet portion 343 and a wider receiver portion 345 adapted to receive the rounded tip 337 on a locking tab 332 from an adjacent prosthesis 300.
- Locking tabs 332 on the opposite end of prosthesis 300 are circumferentially offset with respect to the first end so that adjacent prostheses may interleave and engage with one another.
- Fig. 3 B illustrates how the ends of prostheses 300 with locking tabs 332 engage one another.
- FIG. 3C illustrates prosthesis 300 of Figs. 3A-3B in the expanded configuration and interlocked with an adjacent expanded prosthesis 300.
- U- shaped connectors 322 deflect outwardly, expanding cells 326.
- Struts 320 while still substantially straight, are no longer horizontal and thus the period of the sinusoidal-like wave pattern forming each cell 326 has increased and become more angular to form more of a zigzag, thereby increasing the diameter of the prosthesis.
- Cells 326 which originally appear as a series of horizontally oriented ovals, now appear as a series of triangles or diamonds.
- Sigmoidal connectors 328 maintain the spacing 330 between columns of cells 318.
- Fig. 3D highlights the coupling of locking tabs 332 between adjacent prostheses 300 after expansion.
- FIG. 4A illustrates another embodiment of a prosthesis 400 in the unexpanded configuration, unrolled and flattened out for clarity. This embodiment is similar to the embodiment in Figs. 3A-3D with the major difference being that this embodiment has fewer columns of open cells and different interlocking tabs on either end of the prosthesis.
- FIG. 4A shows a preferred embodiment of a prosthesis illustrated in the unexpanded configuration, unrolled and flattened out for clarity.
- Prosthesis 400 comprises nine substantially parallel columns of 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426, spaced apart by a gap 430 and formed around a central axis 424 so that prosthesis 400 has a tubular or cylindrical shape.
- Each column 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i is formed from an undulating or sinusoidal or zig-zag or wave pattern 418.
- the wave pattern 418 is comprised of substantially axial struts 420 joined together by a U-shaped connector 422.
- the struts 420 are generally parallel to the central axis 424.
- each wave pattern 418 repeats itself sixteen times in each of the nine parallel columns 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426, although this number is not intended to be limiting.
- the number of rows of cells 426 may be increased to provide increased scaffolding of the lumen wall or the number of rows may be decreased to minimize the amount of metal in the prosthesis which contacts the lumen wall.
- the wave pattern 418 in each column is out-of-phase with the adjacent column, therefore the peak of one wave pattern 418 is adjacent to the trough of a wave 418 pattern in an adjacent column.
- sigmoidal shaped connector 428 which joins the ends of U-shaped connector 422 together.
- the sigmoidal connector 428 generally attaches to the apex of the U-shaped connector 422.
- the sigmoidal shaped connector 428 attaches generally to every fourth U-shaped connector 422, in each column 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i, thus there are four sigmoidal shaped connectors 428 between each column 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426. Additionally, the slope of the sigmoidal shaped connectors 428 generally slopes downward between columns 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i open cells 426.
- the sigmoidal shaped connector 428 between column 402a and 402b is attached to U-shaped connector 422 in column 402a at a point generally at the apex of the U-shaped connector 422 and substantially parallel to the axial struts 420.
- the sigmoidal connector 428 slopes downward toward the adjacent U-shaped connector 422 in adjacent column 402b and attaches to the adjacent U-shaped connector 422 at a point generally at the apex of U-shaped connector 422 and substantially parallel to the axial struts 420.
- the sigmoidal shaped connector 422 between columns 402b and 402c similarly joins U-shaped connectors 422, sloping downward.
- Both ends of prosthesis 400 comprise interlocking tabs.
- One end of prosthesis 400 has a locking male tab 432 and the opposite end has a female receiving tab 436.
- Axial struts 436 couple the male locking tab 432 to adjacent U-shaped connectors 422 and therefore there also is a spacing 442 between axial struts 436.
- Female receiving tab 436 also has an enlarged head portion 444 and a narrower neck portion 446.
- the head portion 444 is formed from arcuate struts 448 shaped like a "C” or a "U,” and having bulbous tips 450.
- the arcuate struts 448 form a receptacle 454 which is adapted to interlock with the enlarged head portion 434 of male locking tab 432.
- the neck portion is formed from a wide strut 452 which joins with adjacent axial struts 420, replacing the U-shaped connector 422.
- Female tabs 436 are staggered relative to male tabs 432 so that adjacent prostheses may interlock with each other.
- Fig. 4B illustrates how the ends of prostheses 400 with tabs 432 and 436 engage one another.
- FIG. 5 A shows another embodiment of an interlocking prosthesis 500 in the unexpanded configuration, unrolled and flattened out for clarity. This embodiment is similar to that shown in Figs. 4A-4B with the major difference being the interlocking tabs on either end of the prosthesis 500.
- the overall geometry of prosthesis 500 is the same as prosthesis 400 above.
- prosthesis 500 also has nine substantially parallel columns 502a, 502b, 502c, 502d, 502e, 502f, 502g, 502h and 502i of open cells 526 spaced apart by a gap 530 and formed around a central axis 524 so that prosthesis 500 has a tubular or cylindrical shape.
- Each column 502a, 502b, 502c, 502d, 502e, 502f, 502g, 502h and 502i has the same undulating wave pattern 418 as prosthesis 400 with a sigmoidal connector 528 coupling the nine columns 502a, 502b, 502c, 502d, 502e, 502f, 502g, 502h and 502i together.
- Other aspects of the sigmoidal connector 528 are generally the same as sigmoidal connector 428 described above with respect to Figs. 4A-4B.
- Both ends of prosthesis 500 comprise interlocking tabs.
- One end of prosthesis 500 has a locking male tab 532 and the opposite end has a female receiving tab 536.
- Male tab 532 has a wider head portion 534 defined by an arcuate strut 538 forming a "C" shape and having free ends 539 that may flex, and a narrow neck portion 533 defined by an axial strut 536.
- the axial strut 536 is coupled with the C-shaped arcuate strut 538 approximately at the center of the concave portion of the "C.”
- the axial strut 536 couples the male locking tab 532 to the prosthesis 500 at the apex of U-shaped connector 522 in open cell 526.
- There are four male locking tabs 532 on one end of prosthesis 500 spaced apart every four rows of open cells 526.
- the opposite end of prosthesis 500 has a female receiving tab 536 which includes an enlarged head portion 544 and a narrower neck portion 546.
- the head portion 544 is formed from an arcuate strut 548 shaped like a "C” or a "U,” and having enlarged tips 550 defining a receptacle 551 therein.
- An optional radiopaque marker 553 may be press-fit, welded or bonded into receptacle 551. Radiopaque markers are commonly fabricated from gold, platinum, iridium or tantalum.
- the arcuate strut 548 forms another receptacle 554 having a narrow inlet portion 560 and a wider receiver portion 562 which is adapted to interlock with the enlarged head portion 534 of male locking tab 532.
- the neck portion 546 is formed from a strut 552 which joins with the adjacent axial struts 520 which form open cells 526.
- Strut 552 joins with strut 520 at the apex of U-shaped connector 522.
- Female receiving tabs 536 are staggered with respect to male tabs 532 so that adjacent prostheses 500 may interlock with each other. Prostheses 500 interlock with one another by pressing them together. Fig.
- FIG. 5B illustrates how the ends of prostheses 500 with tabs 532 and 536 engage one another.
- Other interleaving stent embodiments are described in copending U.S. Patent Application No. 10/738,666 filed December 16, 2003 (Attorney Docket No. 021629- 00051 OUS); U.S. Patent Application No. 10/957,079 filed September 30, 2004 (Attorney Docket No. 021629-00271 OUS); and U.S. Provisional Application No. 60/784,309 filed March 20, 2006 (Attorney Docket No. 021629-003600US), the entire contents of which are incorporated herein by reference.
- Prostheses 128 are preferably composed of an elastic or superelastic shape memory alloy such as Nitinol so that the prostheses 128 resiliently self-expand upon release into a vessel by retraction of the sheath 124.
- Other possible materials include a spring temper metal such as stainless steel, cobalt-chromium or ELGILO YTM so the prostheses 128 may self- expand in the body lumen at the target treatment site.
- an inflation balloon is not required but may still be used for predilation of a lesion or augmenting expansion of the self-expanding stent segments 128 (e.g. postdilation or tacking).
- Other materials such as biocompatible polymers may be used to fabricate prosthetic stent segments that self-expand, and these materials may further include bioabsorbable or bioerodable properties.
- prostheses 128 may have any of a variety of common constructions, such as but not limited to those described in U.S. Patent Application Serial No. 10/738,666 filed December 16, 2003 (Attorney Docket No. 02169-00051 OUS), which was previously incorporated by reference.
- Constructions may include for example, closed cell constructions including expansible ovals, ellipses, box structures, expandable diamond structures, etc.
- the closed cells may have complex slotted geometries such as H- shaped slots, I-shaped slots, J-shaped slots, etc.
- Suitable open cell structures include zig-zag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature.
- prosthetic stent segments 128 may be coated, impregnated, infused or otherwise coupled with one or more drugs that inhibit restenosis, such as Rapamycin, Everolimus, Biolimus A9, Paclitaxel, analogs, prodrugs, or derivatives of the aforementioned, or other suitable agents, preferably carried in a durable or bioerodable carrier of polymeric or other suitable material.
- drugs that inhibit restenosis such as Rapamycin, Everolimus, Biolimus A9, Paclitaxel, analogs, prodrugs, or derivatives of the aforementioned, or other suitable agents, preferably carried in a durable or bioerodable carrier of polymeric or other suitable material.
- stent segments 128 may be coated with other types of drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, antiinflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics, endothelial cell attractors or promoters and/or stem cells.
- drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, antiinflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics, endothelial cell attractors or promoters and/or stem cells.
- drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, antiinflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeut
- FIGs. 2A-2E the deployment of selected prostheses to treat a lesion is shown in accordance with an exemplary embodiment. While the embodiment will be described in the context of a femoral artery stent procedure, it should be understood that the invention may be employed in any variety of coronary or peripheral arteries, blood vessels and other body lumens in which stents or tubular prostheses are deployed, including the carotid and iliac arteries, other arteries or veins, as well as non-vascular body lumens such as the ureter, urethra, fallopian tubes, the hepatic and biliary duct and the like.
- the delivery catheter is introduced into a treatment vessel first, by placing an introducer sheath (not illustrated) into the target peripheral artery, typically using a percutaneous procedure such as the Seldinger technique or by surgical cutdown.
- the target vessel is a femoral artery.
- the introducer sheath is then advanced slightly into the femoral artery.
- a guidewire 138 is then inserted through the introducer and advanced into the target vessel V where a lesion L to be treated is located.
- the proximal end of guidewire 138 is then inserted through distal port 156 of nosecone 138 and through inner lumen 135 of inner shaft 134, exiting handle 106 at adapter 108 which is outside the patient's body.
- a guide catheter may also be employed.
- FIG. 2A shows a stent delivery catheter 200 slidably advanced over the guidewire 138 into the vessel V so that nosecone 138 is distal to lesion L.
- Self-expanding tubular prostheses 128 having ends spaced apart are disposed over inner shaft 134 and constrained by outer sheath 124.
- four prostheses 128 are carried by the stent delivery catheter 200, although this is not intended to be limiting. The number of prostheses may be varied to accommodate different lesion lengths.
- Outer sheath 124 has a high hoop strength near the distal end such that the outer sheath 124 is able to prevent the self-expanding prostheses 128 from expanding when the outer sheath 124 is disposed thereover. This may be accomplished by using an outer sheath 124 with a suitable wall thickness or the sheath 124 may also have a distal portion formed from a metal or polymer reinforced with a metallic or polymeric braid to resist radial expansion of the self-expanding prostheses 128.
- each prosthesis 128 has a length approximately 20 mm long.
- the delivery catheter 200 is adapted to deliver a prosthesis having a total length from about 20 mm long, up to 80 mm long, in 20 mm increments.
- Other lengths and quantities of prostheses 128 may be employed and this exemplary embodiment is not meant to limit the scope of the present invention.
- Radiopaque marker 152 is disposed near the proximal end of nosecone 138 or alternatively, radiopaque marker 152 may be disposed on inner shaft 134 near the proximal end of nosecone 138.
- Radiopaque marker 153 is disposed near the distal end of pusher 144.
- Radiopaque markers are typically fabricated from gold, platinum, iridium or tantalum and are well known in the art. Radiopaque markers 152 and 153 help an operator to visualize the tip of delivery catheter 200 under fluoroscopy as well as determining the number of prostheses 128 to deploy to traverse the lesion L.
- an optional radiopaque marker 151 may be disposed near the distal end of outer sheath 124 so that sheath position may also be observed under fluoroscopy.
- Pusher tube 144 is also seen in Fig. 2 A disposed over inner shaft 134.
- the distal end pusher tube 144 comprise several resilient fingers 166 which radially extend outward such that pusher tube 144 may be retracted proximally past prostheses 128 but when pusher 144 is advanced distally, the resilient fingers 166 engage a prosthesis 128 so that the prosthesis 128 is advanced distally as the pusher 144 is advanced.
- Prothesis 128 Distal motion of prosthesis 128 allows adjacent prostheses 128 having interlocking tabs 162 to engage with receptacle 164, eliminating gap 160.
- Pusher tube 144 also serves as a backstop to prevent proximal motion of prostheses 128. Additional details on these elements will be discussed in greater detail below, with respect to Figs. 2B-2E.
- the lesion L to be treated is typically visualized by introducing contrast media into the target vessel V and observing the resulting image under a fluoroscope.
- Radiopaque markers 152, 153 and optional radiopaque marker 151 are used to help visualized the position of the delivery catheter 200 relative to the lesion L as well as to visualize the length of prostheses 129 selected for deployment relative to the target lesion L.
- Radiopaque marker 152 is typically disposed near the proximal end of nosecone 136 but in alternative embodiments marker 152 may also be disposed on the inner shaft 134 near the proximal end of nosecone 136.
- Radiopaque marker 152 is near the distal edge of lesion L.
- Pusher 144 will later be retracted proximally until it is near the proximal end of lesion L.
- the lesion therefore traverses the region between radiopaque markers 152 and 153.
- An optional radiopaque marker 151 disposed near the distal end of outer sheath 124 allows the user to observed sheath position during the stenting procedure.
- pusher tube 144 is retracted proximally until radiopaque marker 153 is near the proximal edge of lesion L.
- the distal end 166 pusher tube 144 comprises a plurality of resilient, radially extending inclined fingers 166, thus pusher tube 144 may be retracted proximally under prostheses 128 without displacing them. Retracting pusher 144 selects the number of prostheses 129 to be deployed and that will provide a total prosthesis 126 length that traverses the length of lesion L.
- Pusher 144 tube extends to the proximal end of delivery catheter 200 and retraction of pusher tube 144 is accomplished using a control mechanism such as slider 140 in Figs. IA or 1C.
- prostheses 129 are advanced distally until they engage and interlock with one another.
- Pusher tube 144 is advanced distally until it engages the proximal -most end of the proximal prosthesis 129 selected for delivery.
- the distal end of pusher tube 144 has resilient and radially extending inclined fingers 166. Advancing pusher tube 144 distally causes the fingers 166 to engage with the proximal-most prosthesis 129 selected for delivery. Further advancement of pusher tube 144 advances the selected prostheses 129 until the distal- most prosthesis 129 of those selected butts up against the proximal end of nose cone 136.
- Nosecone 136 has a recessed region 145 in which interlocking tab 162 may be received so that the distal-most prosthesis 129 can fit flush against nosecone 136.
- the gap 160 that existed between prostheses 128 prior to deployment therefore is reduced significantly to a slight gap or no gap 161 as prosthesis 129 ends are engaged with one another during deployment. Additionally, if after pushing prostheses 129 together, a longer total length is required, the steps illustrated in Figs. 2B-2C may be repeated in order to create a longer "stent train.” [0079] In Fig.
- FIG. 2D the constraint covering prostheses 129 selected for deployment is removed.
- outer sheath 124 is retracted proximally. Retraction of outer sheath 124 is accomplished using a control mechanism such as slider 102 in Figs. IA or 1C. Retracting outer sheath 124 removes the constraint and exposes prostheses 129, allowing them to self-expand into lesion L. As outer sheath 124 is retracted, the exposed portion of prostheses 129 self-expand to a final shape 137 matching lesion L.
- Prosthesis 129 is prevented from jumping or "watermelon seeding" away from delivery catheter 200 because the prosthesis 129 being deployed is interlocked with an adjacent prosthesis 129 maintained in the delivery catheter 200 and constrained by outer sheath 124.
- the position of the outer sheath 124 may be monitored by the operator by visualizing an optional radiopaque marker 151 on the distal end of outer sheath 124, or the operator may determine sheath position by observing the position of slider 102.
- Pusher tube 144 also serves as a backstop to prevent proximal displacement of prostheses 129 that might occur as a result of outer sheath 124 passing distally thereover.
- outer sheath 124 is retracted proximally until all prostheses 129 selected for deployment are unconstrained and they self-expand into the lesion L. If an additional prosthesis 128 is required to treat the lesion L, the pusher tube 144 may be retracted proximally so as to select an additional prosthesis 128 and it may be deployed in similar manner to that previously described. Once all prostheses 129 have been deployed, outer sheath 124 may be advanced distally until it engages nosecone 136 and the entire delivery catheter 200 may be removed from the treatment site. Alternatively, inner shaft 134 may be retracted into outer sheath 124 until nosecone 136 engages outer sheath 124 and then the entire delivery catheter 200 may be withdrawn.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Abstract
A catheter for delivering a prosthesis to a treatment site in a body lumen comprises an elongate flexible member and a sheath slidably disposed thereover. A plurality of self-expanding tubular prostheses are carried in axially spaced apart locations along the elongate member, within the sheath. The prostheses may be selectively interlocked with one another and are constrained by the sheath in a radially contracted configuration. The prostheses are separately releasable from the sheath when the sheath is retracted relative to the elongate member. The catheter also has a pusher member slidably disposed along the elongate member within the sheath. The pusher is adapted to move past the prostheses in a first direction without displacing the prostheses, while in a second direction the pusher engages a selected prosthesis so as to move the prosthesis with the pusher to interlock the selected prosthesis with a second prosthesis.
Description
DEVICES AND METHODS FOR CONTROLLING EXPANDABLE PROSTHESES DURING DEPLOYMENT
BACKGROUND OF THE INVENTION [0001] 1. Field of the Invention. This invention relates generally to medical apparatus and methods, and more specifically to vascular catheters, stents and stent delivery systems for use in the coronary and peripheral arteries as well as other vessels and body lumens.
[0002] Stenting is an important treatment option for patients with occlusive disease in the vasculature as well as other systems such as the biliary tract. The stenting procedure involves placing a tubular prosthesis at the site of a lesion, typically within a diseased artery. The procedure is performed in order to maintain the patency of the artery and is often performed after a primary treatment such as angioplasty. Early stent results suffered from high rates of restenosis, i.e. the tendency for the stented vessel, such as an artery, to become re-occluded following stent implantation. However, in recent years, restenosis rates have decreased substantially, due to many improvements in stent delivery, stent technology as well as the use of drugs. As a result, the number of stent related procedures being performed worldwide continues to dramatically increase.
[0003] Stents are typically either self-expanding or balloon expandable and they are delivered to the arteries using long, flexible vascular catheters typically inserted percutaneously through the patient's femoral artery. For balloon expandable stents, the stents are usually mounted over a balloon on the delivery catheter, thus, when the balloon is inflated, it expands which correspondingly expands and deforms the stent to the desired diameter. The balloon can then be deflated and removed, leaving the stent in place. For self- expanding stents, the stent is released from the delivery catheter and it resiliency expands into engagement with the vessel wall. Self-expanding stents are often used in the peripheral vascular system since they are more resilient than balloon expandable stents. Resilient stents are better suited for implantation into regions of the body closer to the body's surface, such as a peripheral artery, since the stent's resilience helps minimize damage or crashing caused by body movement or externally applied forces.
[0004] Self-expanding stents may also be used in the coronary arteries and may provide advantages over balloon expandable stents. Balloon expandable stents are typically expanded with a balloon having a constant diameter and therefore the expanded stent may not conform well to a coronary artery having variations in diameter due to tortuosity or taper. Therefore, there is a potential for gaps between the outer stent surface and the inner surface of the artery wall. These gaps may lead to thrombus formation and recently, there has been concern that this effect is pronounced in drug eluting stents because the drug delays endothelialization of the stent surface, allowing the gaps to remain for a longer period of time. Self-expanding stents expand until the outer stent surface is constrained by contact with a vessel wall. Therefore, gaps between the stent and the arterial wall are minimized thus helping to reduce thrombus formation. Companies such as Devax (Irvine, CA) and Cardiomind (Sunnyvale, CA) are developing self-expanding stents for implantation into the coronary arteries.
[0005] Current stent delivery technology suffers from a number of drawbacks which can make delivery of stents challenging. In particular, current stent delivery catheters often employ stents having fixed lengths. The proper selection of fixed length stents requires accurate knowledge of the lesion length being treated. While lesion length may be measured prior to stent deployment using angiography and fluoroscopy, these measurements are often inaccurate. Thus, if an incorrectly sized stent is introduced to a treatment site, it must be removed from the patient along with the delivery catheter and replaced with a different device having the correct stent size. This prolongs the procedure, increases waste and results in a more costly procedure.
[0006] Additionally, and especially in the case of peripheral vascular disease, lesions are often long and diffuse. A single long stent may be deployed to treat a single lesion or to span multiple lesions, however this is not optimal since longer stents tend to have higher fracture and restenosis rates as compared with shorter stents. Therefore, placement of multiple shorter stents in a long lesion may be advantageous instead of deploying a single long length stent.
[0007] The use of "custom length" stents as an alternative to fixed length stents has been proposed. One such approach for providing a custom length stent has been to use segmented stents for treatment in which only some of the stents are deployed for treatment. Several exemplary systems are described in several copending, commonly assigned applications which are listed below. In these systems, the stent segments are deployed by selective
advancement over the delivery catheter. After delivering an initial group of segments, the catheter may be repositioned to a new treatment site and a further group of segments can then be deployed. These systems enable treatment of multiple lesions with a single device and may contain up to fifty segments.
[0008] While this technology represents a significant improvement over earlier stent delivery systems, in the case of self-expanding stents, accurate delivery of the stents to a treatment site can present other challenges. Because self-expanding stent segments tend to rapidly spring open upon deployment, it is difficult to control their placement. In some cases, the stents may actually eject or "watermelon seed" away from the delivery catheter. Therefore, a delivery system that allows more precise control of stent deployment and placement is desirable.
[0009] Another challenge with existing "custom length" stent delivery systems is that to deliver multiple stent segments to multiple lesion sites requires an intricate delivery system that can be somewhat complex to use. Thus, a simpler delivery system that allows length customization is desirable, especially for use in treating long lesions in the peripheral and coronary vasculature.
[0010] For the reasons above, as well as others, it would be desirable to provide improved prosthetic stents and delivery catheters. It would be particularly desirable to provide catheters which enable stent length to be customized using multiple stent segments. It is also desirable to provide a delivery system that is flexible and can track torturous vessels and that has a simple construction and is less costly and easy to use in deploying a selectable number of stent segments to a treatment site. It is further desirable to provide a stent delivery catheter that can control the delivery and placement of self-expanding stents in the peripheral and coronary vascular system.
[0011] 2. Description of the Background Art. Prior publications describing catheters for delivering multiple segmented stents include: U.S. Publication Nos. 2004/0098081, 2005/0149159, 2004/0093061, 2005/0010276, 2005/0038505, 2004/0186551 and 2003/013266. Prior related unpublished co-pending U.S. patent applications include serial number 11/148,713, filed June 8, 2005 (Attorney Docket No. 14592.4002), entitled "Devices and Methods for Operating and Controlling Interventional Apparatus"; serial number
11/148,545, filed June 8, 2005 (Attorney Docket No. 14592.4005), entitled "Apparatus and Methods for Deployment of Multiple Custom-Length Prosthesis"; serial number 11/344,464,
filed January 30, 2006 (Attorney Docket No. 021629-003500US), entitled "Apparatus and Methods for Deployment of Custom-Length Prostheses"; serial number 60/784,309, filed March 20, 2006 (Attorney Docket No. 021629-003600US), entitled "Apparatus and Methods for Deployment of Linked Prosthetic Segments"; serial number 11/469,773 filed September 1 , 2006 (Attorney Docket No. 021629-004000US), entitled "Custom Length Stent Apparatus"; and serial number 11/462,951, filed August 7, 2006 (Attorney Docket No. 021629-004100US), entitled "Custom Length Stent Apparatus." The full disclosures of each of these patents and applications are incorporated herein by reference.
BRIEF SUMMARY OF THE INVENTION
[0012] The invention generally provides for the delivery of self-expanding prostheses with a flexible delivery catheter capable of navigating vessels such as the peripheral and coronary arteries. The delivery catheter permits controlled deployment of a selectable number of prosthetic segments at a treatment site, thus allowing customization of prosthesis length while the delivery catheter is in a body lumen at a treatment site. Customization of prosthesis length in situ permits better matching of the prosthesis length to the lesion length being treated.
[0013] The terms "stent" and "stenting" are defined to include any of the array of expandable prostheses and scaffolds which are introduced into a lumen at a target treatment site and expanded in situ thereby exerting a radially outward force against the lumen wall. The prosthesis of the present invention comprises a closed or an open lattice structure and is typically fabricated from an elastic material or self-expanding material, including superelastic materials such as nickel-titanium alloys like Nitinol, or spring temper stainless steels or polymers, and the lattice structures are commonly constrained radially during delivery and upon deployment the constraining structure is removed, allowing the prosthesis to "self- expand" at the target site. The terms "stent," "prosthesis," "prosthetic segment" and "stent segment" refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within a body lumen.
[0014] In a first aspect of the present invention, a catheter for delivering a prosthesis to a treatment site in a body lumen comprises an elongate flexible member having a proximal end and a distal end. A sheath is slidably disposed over the elongate flexible member and a plurality of self-expanding tubular prostheses are carried in axially spaced-apart locations
along the elongate flexible member, within the sheath. The plurality of self-expanding tubular prostheses are adapted to be selectively interlocked with one another and they are constrained by the sheath in a radially contracted configuration. The prostheses are separately releasable from the sheath as the sheath is retracted relative to the elongate flexible member.
[0015] The catheter also includes a pusher member that is slidably disposed along the elongate flexible member within the sheath and the pusher is adapted to move past the prostheses in a first direction, usually without displacing the prostheses. In a second direction, the pusher member engages a selected prosthesis and the pusher can move the prosthesis so as to interlock the selected prosthesis with a second prosthesis. The pusher member may have an engagement member which is deflectable radially inward by contact with the prostheses when moved in the first direction while in the second direction the engagement member engages the prostheses selected for deployment. Sometimes the engagement member may comprise a plurality of flexible fingers that extend radially outward from the pusher member. The pusher member often may exert substantially greater axial force against the plurality of self-expanding tubular prostheses when the pusher member is advanced distally than when the pusher member is retracted proximally.
[0016] Sometimes the catheter comprises a stopping element that is axially disposed along the elongate flexible member. The stopping element is adapted to prevent the plurality of self-expanding tubular prostheses from being displaced past the distal end of the elongate flexible member when the pusher member is advanced distally. The catheter may also comprise a handle that is usually near the proximal end of the elongate flexible member and the handle usually has a control mechanism adapted to move the sheath and pusher member. Sometimes the catheter may also include a central lumen disposed within the elongate shaft that can carry a guidewire.
[0017] In another aspect of the present invention, a method for delivering a prosthesis to a body lumen having a lesion with a length comprises introducing into the body lumen one or more self-expanding tubular prostheses. The prostheses are carried at axially spaced apart locations along an elongate flexible member and they are constrained in a contracted configuration within a sheath. Selecting a first group of the tubular prostheses for delivery picks a first group of prostheses that has a combined length substantially traversing the lesion. Bringing the first group into engagement with each other within the sheath interlocks
prostheses in the first group with one another and uncovering the first group from the sheath removes the constraint from the first group so they may expand at the first treatment site while a second group of prostheses is retained within the sheath. Sometimes the method may further comprise selecting one or more additional self-expanding tubular prostheses and bringing them into to engagement with the first group within the sheath so that the additional prostheses interlock with the first group.
[0018] Selecting a first group of prostheses may comprise proximally retracting a pusher member. The pusher member often has a flexible engagement member that is deflected by the prostheses as the pusher member is retracted proximally. Bringing the first group into engagement with each other may comprise engaging at least one of the first group of prostheses with a pusher member and advancing the pusher member distally. Bringing the first group into engagement with each other may also comprise stopping the first group of prostheses from moving distally with a stopping element that is disposed on the elongate flexible member. Engaging the at least one prosthesis may include engaging the prosthesis with a flexible engagement member that is disposed on the pusher member and uncovering the first group can involve proximally retracting the sheath. The method may also comprise
releasing a therapeutic agent from the first group of prostheses after expansion at the treatment site. Often, the therapeutic agent may comprise an anti-restenosis agent.
[0019] In still another aspect of the present invention, a self-expanding tubular prosthesis comprises a plurality of self-expanding tubular rings that have a plurality of axial struts and a plurality of connectors coupling adjacent struts together. The axial struts and connectors also may form a plurality of substantially parallel and spaced apart columns of open cells. The axial struts and connectors often form a substantially zig-zag pattern and a bridge member couples adjacent tubular rings together. A plurality of bridges, which may be sigmoidally shaped may join the columns of open cells or rings together. Sometimes the connectors are U-shaped and often the columns of open cells are out of phase with an adjacent column. The prosthesis is usually adapted to be interlocked with an adjacent prosthesis when pressed together and the prostheses remain interlocked with one another even after radial self- expansion. The prosthesis often may have an interlocking tab on one end of the tubular rings that is adapted to interlock with an adjacent tubular ring when the rings are pressed together.
[0020] The interlocking tab may comprise a strut that defines an aperture which is adapted to hold a radiopaque marker. The bridge may be coupled to a connector and have an axially
extending strut that joins the bridge with the connector. The bridge may connect to an apex of the connector, which may be U-shaped. The interlocking tab may comprise a narrow neck region and an enlarged head region which may be C-shaped. The enlarged head region may have an arcuate strut defining a narrow inlet portion and a wider receiving portion. The receiving portion is usually adapted to receive and interlock with an interlocking tab on an adjacent ring.
[0021] The enlarged head region may have a plurality of arcuate struts that are coupled to the ring with a plurality of axial struts and the neck region may comprise a plurality of axial struts. The enlarged head region may also comprise an arcuate strut that forms a C-shape and that is coupled to the ring with an axial strut.
[0022] The prosthesis may also have a female receiving tab on an end of the prosthesis opposite of the interlocking tab. The female tab may include an arcuate strut that defines a receptacle, sometimes C-shaped, which can receive and interlock with an enlarged head of an adjacent prosthesis. The arcuate strut may be coupled to a ring with an axial strut. The female tab may also comprise an arcuate strut that defines an aperture which can hold a radiopaque marker. The prosthesis may further comprise a therapeutic agent that is carried on the prosthesis and that may be released therefrom. Often, the therapeutic agent comprises an anti-restenosis agent. The prosthesis often has an overall length in the range from about 5 mm to about 50 mm. Sometimes each of the prostheses have the same length, although sometimes at least one of the prostheses may have a different length than another of the prostheses.
[0023] These and other embodiments are described in further detail in the following description related to the appended drawing figures.
BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Fig. 1 A is a perspective view of an over-the-wire stent delivery catheter in accordance with one embodiment of the present invention.
[0025] Fig. IB is a cross section of the distal end of the stent delivery catheter illustrated in Fig. IA.
[0026] Fig. 1 C is a perspective view of a stent delivery catheter in accordance with another embodiment of the present invention.
[0027] Figs. 2A-2E illustrate selection and deployment of prostheses in accordance with an exemplary embodiment.
[0028] Fig. 3 A shows a top view of a prosthesis after it has been unrolled and flattened.
[0029] Fig. 3B shows interlocking of two of the prostheses illustrated in Fig. 3A.
[0030] Fig. 3C shows interlocking of two of the prostheses illustrated in Fig. 3 A after expansion.
[0031] Fig. 3D highlights the interlocking of prostheses shown in Fig. 3C.
[0032] Fig. 4A shows a top view of another embodiment of a prosthesis after it has been unrolled and flattened.
[0033] Fig. 4B shows interlocking of two of the prostheses illustrated in Fig. 4A.
[0034] Fig. 5 A shows a top view of still another embodiment of a prosthesis after it has been unrolled and flattened.
[0035] Fig. 5B shows interlocking of two of the prostheses illustrated in Fig. 5 A.
DETAILED DESCRIPTION OF THE INVENTION [0036] In the drawings like numerals describe substantially similar components. Referring now to Fig. IA, a preferred embodiment of an over-the-wire prosthesis delivery catheter 50 comprises a catheter shaft 120 which includes a sheath 124 slidably disposed over a pusher tube 144 which is in turn slidably disposed over an inner shaft 134 (seen in Fig. IB). A prosthesis 126 is carried near the distal end of the catheter shaft 120 and is covered by sheath 124. Pusher tube 144 is adapted to move past the prosthesis 126 in one direction and to push prosthesis 126 in a second direction and this will be described in greater detail below. A tapered nosecone 136 having a distal exit port 156, composed of a soft elastomeric material to minimize trauma to the vessel during advancement of the delivery catheter 50, is attached to the inner shaft 134 distally of the prosthesis 126. Prosthesis 126 preferably comprises a plurality of self-expanding prostheses 128 mounted under sheath 124 and disposed over inner shaft 134. Sheath 124 covers the self-expanding prostheses 128 and constrains them in a radially contracted configuration until the delivery catheter 50 has been properly positioned at a treatment site. A radiopaque marker 152 (Fig. IB) near the proximal end of nosecone 136 or optionally a radiopaque marker 151 near the distal end of sheath 124 and a radiopaque marker 153 near the distal end of pusher tube 144 help the operator visualize the delivery
catheter under a fluoroscope during a stent procedure. Radiopaque marker 153 also helps the operator to view the distance the pusher 144 has been retracted relative to the radiopaque marker 152 adjacent to nosecone 136. This helps the operator determine how many prostheses 128 to deploy and will be discussed in greater detail below.
[0037] As shown in Fig. IA, handle 106 is attached to a proximal end 112 of the outer sheath 124. The handle 106 performs several functions, including retracting and advancing outer sheath 124 and pusher tube 144 thereby allowing selection and exposure of prosthetic segments 128 so that they may self-expand and be deployed. A guidewire 138 is positioned slidably through adapter 108 of handle 106 and extends through inner lumen 135, exiting distal port 156.
[0038] Handle 106 includes a housing 110 which encloses the internal components of the handle 106. Handle 106 allows a physician operator to advance or retract outer sheath 124 and pusher tube 144. The amount of retraction of sheath 124 and pusher tube 144 determine the number of individual prostheses 128 to be deployed thereby establishing the overall length of the prosthesis 126 while ensuring accurate delivery of the individual prostheses 128. The inner shaft 134 is preferably fixed to the handle housing 110, while both outer sheath 124 and pusher tube 144 are coupled to slide mechanisms 102 and 140, respectively. Slide mechanisms 102 and 140 allow both the outer sheath 124 and pusher tube 144 to be retracted and advanced relative to handle 106. Optionally, a single slide mechanism could be used to control motion of the outer sheath 124 and pusher tube 144. Other handle embodiments are described in U.S. Patent Application No. 11/614,271 (Attorney Docket No. 021629- 00221 OUS), the entire contents of which are hereby incorporated by reference.
[0039] The slide mechanism 102 translates along calibrated slot 104. Slide mechanism 102 is coupled with outer sheath 124. Slide mechanism 102 is adapted to retract the outer sheath 124 a selected distance so that the self-expanding tubular prostheses 128 may be exposed for delivery. As sheath 124 is retracted, the distal most section of prosthesis 128 begins to expand. Additional details on the operation of sheath 124 and pusher 144 are described below. The slide mechanism 102 may include optional visual markers 148 that allow an operator to easily determine the length or number of prostheses that have been exposed. In preferred embodiments, slide mechanism 102 may have detents or a ratchet that provides audible or tactile feedback to the operator to facilitate operation of the stent delivery catheter 50 without requiring direct visualization during operation.
[0040] Handle 106 also comprises a second control mechanism 140 that translates along calibrated slot 142. Slide mechanism 140 is coupled with the pusher tube 144 and is adapted to retract or advance pusher tube 144 independently of outer sheath 124. Retracting pusher tube 144 allows the number of prostheses 128 to be selected for deployment. Advancement of pusher tube 144 advances the prostheses 128 distally and couples the prostheses 128 together. Slide mechanism 140 may also include optional visual markers 150 that help the physician determine the position of the pusher tube 144 or the number of prostheses 128 selected for deployment or the total length thereof. Additionally, the slide mechanism 140 may comprise detents or a ratchet that further assists physician operation by providing audible or tactile feedback. Further details on operation of the pusher tube 144 and the outer sheath 124 are discussed below.
[0041] Handle 106 also permits connection of an external fluid source via adapter 108 attached to the proximal end of handle 106. Fluid may then be injected at the proximal handle end and infused along a lumen in inner shaft 134 into a patient via distal port 156 or other infusion ports (not shown) near the distal end of the delivery catheter 50. The adaptor 108, preferably a Luer connector, is configured to be fiuidly coupled with a fluid source such as a syringe or intravenous bag. In alternative embodiments adaptor 108 may be fluidly connected to an inflation lumen 135 in inner shaft 134 which is connected to an optional inflatable balloon (not shown) near the distal end of the catheter 50. An inflation device which may be any commercially available balloon inflation device such as those sold under the trade name "Indeflator™," manufactured by Abbott (formerly Guidant Corporation of Santa Clara, CA) may then be connected to adaptor 108 to deliver an inflation fluid to the balloon.
[0042] Additional details on materials and construction of other suitable handles and control mechanisms are described in co-pending U.S. Patent Application No. 11/148,713, filed June 8, 2005, (Attorney Docket No. 14592.4002), entitled "Devices and Methods for Operating and Controlling Interventional Apparatus," and co-pending United States Publication No. 2005/0149159, entitled "Devices and Methods for Controlling and Indicating the Length of an Interventional Element," and Application No. 11/614,271, filed December 21, 2006, (Attorney Docket No. 021629-00221 OUS, formerly 021629-003800US), entitled "Custom Length Stent Apparatus," the full disclosures of which are incorporated herein by reference.
[0043] Outer sheath 124 may be composed of any of a variety of biocompatible materials, such as but not limited to a polymer like PTFE, FEP, polyimide, Nylon or Pebax, and may be reinforced with a metallic or polymeric braid to resist radial expansion of self-expanding prostheses 128. Similar materials may also be used for the inner shaft 134. Both the inner shaft 134 and outer sheath 124 may also be fabricated from metals such stainless steel or nickel-titanium alloys like nitinol.
[0044] Pusher tube 144 is seen in Fig. IB. Pusher tube 144 is an elongate tube having a central lumen that is slidably disposed over inner shaft 134 and under outer sheath 124. The proximal end of pusher tube 144 is coupled with handle 106 as discussed above. The distal end of pusher 144 is adapted to slide under prostheses 128 when pusher 144 is retracted and to engage a prosthesis 128 and move it distally when pusher 144 is advanced distally. The pusher 144 therefore selects the number of prostheses 128 for delivery and provides enough force to interlock prostheses 128 together as will be discussed below. Pusher tube 144 is often an extruded polymer tube, manufactured from similar materials as the outer sheath 124 or inner shaft 134. The distal tip of pusher 144 typically comprises resilient fingers 166 which may be a polymer or a metal ring with resilient fingers 166 formed from metals such as spring temper stainless steel or nickel-titanium alloy such as nitinol bonded or welded to the distal end of pusher 144. Pusher tube 144 may also be made from nitinol tubing with resilient fingers on the distal end.
[0045] Additional aspects of the luminal prosthesis delivery system are described in U.S. Patent Application Serial No. 10/306,813, filed November 27, 2002 (Attorney Docket No. 021629-000320US); U.S. Patent Application Serial No. 10/637,713, filed August 8, 2003 (Attorney Docket No. 021629-000340US); U.S. Patent Application Serial No. 10/738,666, filed December 16, 2003 (Attorney Docket No. 021629-00051 OUS); and U.S. Patent Application Serial No. 11/104,305, filed April 11, 2005 (Attorney Docket No. 021629- 003300US); the full disclosures of which are hereby incorporated by reference.
[0046] Fig. 1 C illustrates another embodiment of a prosthesis delivery catheter 100 similar to delivery catheter 50 described in Fig. IA, except that delivery catheter 100 now comprises a guidewire tube and is not a simple over the wire catheter. Delivery catheter 100 comprises a catheter shaft 120 which includes a sheath 124 slidably disposed over a pusher tube 144 which is in turn slidably disposed over an inner shaft 134 (seen in Fig. 2A). A prosthesis 126 is carried near the distal end of the catheter shaft 120 and is covered by sheath 124. Pusher
tube 144 is adapted to move past the prosthesis 126 in one direction and to push prosthesis 126 in a second direction as described further below. A tapered nosecone 136 having a distal exit port 156, composed of a soft elastomeric material to minimize trauma to the vessel during advancement of the delivery catheter 50, is attached to the inner shaft 134 distally of the prosthesis 126. Prosthesis 126 preferably comprises a plurality of self-expanding prostheses 128 mounted under sheath 124 and disposed over inner shaft 134. Sheath 124 covers the self-expanding prostheses 128 and constrains them in a radially contracted configuration until the delivery catheter 100 has been properly positioned at a treatment site. A radiopaque marker 152 (Fig. 2A) near the proximal end of nosecone 136 or optionally a radiopaque marker 151 near the distal end of sheath 124 and a radiopaque marker 153 near the distal end of pusher tube 144 help the operator visualize the delivery catheter under a fluoroscope during a stent procedure. Radiopaque marker 153 also helps the operator to view the distance the pusher 144 has been retracted relative to the radiopaque marker 152 adjacent to nosecone 136. This helps the operator determine how many prostheses 128 to deploy and will be discussed in greater detail below.
[0047] A guidewire tube 122 is slidably positioned through sheath 124 and inner shaft 134 proximal to the prosthesis 126. A guidewire 138 is positioned slidably through guidewire tube 122 and nosecone 136 and exits a distal exit port 156, extending distally thereof. Additional details on guidewire tube 122 are disclosed in copending U.S. Patent Application No. 10/814,581 (Attorney Docket No. 021629-001000US), the entire contents of which are hereby incorporated by reference.
[0048] As shown in Fig. 1C, a handle 106 is attached to a proximal end 112 of the outer sheath 124. The handle 106 generally takes the same form as handle 106 which was previously described above with reference to Fig. IA and controls the movement of outer sheath 124 and pusher tube 144. Fig. 1C shows two sliders 102, 140 used to control sheath 124 and pusher 144, however, optionally, a single slide mechanism could be used to control motion of the outer sheath 124 and pusher tube 144. Other handle embodiments are described in U.S. Patent Application No. 11/614,271 (Attorney Docket No. 021629- 00221 OUS), the entire contents of which have previously been incorporated by reference. Additional details on materials and construction of other suitable handles and control mechanisms have also been described in co-pending U.S. Patent Application No. 11/148,713, filed June 8, 2005, (Attorney Docket No. 14592.4002), entitled "Devices and Methods for Operating and Controlling Interventional Apparatus," as well as co-pending United States
Publication No. 2005/0149159, entitled "Devices and Methods for Controlling and Indicating the Length of an Interventional Element," the full disclosures of which are incorporated herein by reference.
[0049] Both outer sheath 124 and guidewire 138 each extend through a slider assembly 132 slidaby disposed on the catheter body 120 at a point between its handle 106 and prostheses 128. The slider assembly 132 is adapted for insertion into and sealing with a hemostasis valve, such as on an introducer sheath or guiding catheter, while still allowing relative movement of the outer sheath 124 relative to the slider assembly 132. The slider assembly 132 includes a slider tube 118, a slider body 116, and a slider cap 1 14.
[0050] Outer sheath 124 may be composed of any of a variety of biocompatible materials, such as but not limited to a polymer like PTFE, FEP, polyimide, Nylon or Pebax, and may be reinforced with a metallic or polymeric braid to resist radial expansion of self-expanding prostheses 128. Similar materials may also be used for the inner shaft 134. Both the inner shaft 134 and outer sheath 124 may also be fabricated from metals such as stainless steel or nickel-titanium alloys like nitinol.
[0051] Pusher tube 144 is seen in Fig. 2A. Pusher tube 144 generally takes the same form as pusher 144 in Fig. IB and is an elongate tube having a central lumen that is slidably disposed over inner shaft 134 and under outer sheath 124. The proximal end of pusher tube 144 is coupled with handle 106 as discussed above. The distal end of pusher 144 is adapted to slide under prostheses 128 when pusher 144 is retracted and to engage a prosthesis 128 and move it distally when pusher 144 is advanced distally. The pusher 144 therefore selects the number of prostheses 128 for delivery and provides enough force to interlock prostheses 128 together as will be discussed below. Pusher tube 144 may be fabricated similarly as previously described.
[0052] Additional aspects of the luminal prosthesis delivery system are described in U.S. Patent Application Serial No. 10/306,813, filed November 27, 2002 (Attorney Docket No. 021629-000320US); U.S. Patent Application Serial No. 10/637,713, filed August 8, 2003 (Attorney Docket No. 021629-000340US); U.S. Patent Application Serial No. 10/738,666, filed December 16, 2003 (Attorney Docket No. 021629-000510US); and U.S. Patent Application Serial No. 11/104,305, filed April 11, 2005 (Attorney Docket No. 021629- 003300US); the full disclosures of which are hereby incorporated by reference.
[0053] Prosthesis 126 in Figs. 1 A-IC is composed of one or more prostheses 128. Prostheses 128 are disposed over the inner shaft 134 and under sheath 124. Each prosthesis or segment 128 has interlocking tabs on each end and is about 3-50 mm in length, more typically about 10-30 mm in length and preferably being about 15-25 mm in length. Usually 2-20, more typically 2-15 and preferably 5-10 prostheses 128 are positioned axially over the inner shaft 134. Prostheses 128 are preferably positioned with a spacing in between prostheses 128. The spacing is typically between about 0.5 mm and about 1 mm. During selection and deployment of the prostheses 128, the prostheses 128 selected for deployment are pressed together so that interlocking tabs engage and the prostheses 128 are coupled together. Thus, prostheses 128 may be deployed individually or in groups of two or more at a single treatment site within the vessel lumen.
[0054] In preferred embodiments the adjacent ends have axially extending members that interleave and engage with one another. In an embodiment seen in Fig. 3A, the geometry of prosthesis 300 is illustrated in an unexpanded configuration, unrolled and flattened out for clarity. In Fig. 3 A, prosthesis 300 comprises eleven substantially parallel columns 302a,
302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326, spaced apart by a gap 330 and formed around a central axis 324 so that prosthesis 300 has a tubular or cylindrical shape. Each column 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k is formed from an undulating or sinusoidal or zig-zag or wave pattern 318. The wave pattern 318 is comprised of substantially axial struts 320 joined together by a U-shaped connector 322. The struts 320 are generally parallel to the central axis 324.
[0055] In this embodiment, each wave pattern 318 repeats itself sixteen times in each of the eleven parallel columns 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326, although this number is not intended to be limiting. The number of rows of cells may be increased to provide increased scaffolding of the lumen wall or the number of rows may be decreased to minimize the amount of metal in the prosthesis which contacts the lumen wall. The wave pattern 318 in each column is out-of-phase with the adjacent column, therefore the peak of one wave pattern 318 is adjacent to the trough of a wave 318 pattern in an adjacent column. In addition, the parallel columns 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326 are joined together by a sigmoidal shaped connector 328 which joins the ends of U-shaped connector 322 together.
[0056] The sigmoidal connector 328 generally attaches to the apex of the U-shaped connector 322. Also, the sigmoidal shaped connector 328 attaches generally to every fourth U-shaped connector 322, in each column 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k, thus there are four sigmoidal shaped connectors 328 between each column 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326.
Additionally, the slope of the sigmoidal shaped connectors 328 generally slopes downward between columns 302a, 302b, 302c, 302d, 302e, 302f, 302g, 302h, 302i, 302j, 302k of open cells 326. For example, the sigmoidal shaped connector 328 between column 302a and 302b is attached to U-shaped connector 322 in column 302a at a point generally at the apex of the U-shaped connector 322 and substantially parallel to the axial struts 320. The sigmoidal connector 328 slopes downward toward the adjacent U-shaped connector 322 in adjacent column 302b and attaches to the adjacent U-shaped connector 322 at a point generally at the apex of U-shaped connector 322 and substantially parallel to the axial struts 320. The sigmoidal shaped connector 322 between columns 302b and 302c similarly joins U-shaped connectors 322, sloping downward. This pattern repeats across the prosthesis 300 so that there are ten sets of sigmoidal shaped connectors 328 with downward slopes. Additionally, sigmoidal shaped connectors 322 are staggered such that across any row of open cells 326, a sigmoidal shaped connector 322 couples columns of open cells 326 every fourth gap 330.
[0057] Both ends of prosthesis 300 also comprise locking tabs 332 having a narrow neck portion 333 and a wider head portion 335 defined by curved strut 338. Each locking tab 332 is joined to the body of the prosthesis 300 by an axial strut 340 which join to every fourth U- shaped connector 322 at its apex. Strut 338 defines a U-shape or C-shape with enlarged and rounded tips 337 that define a receptacle 339 therein. In some embodiments, the receptacle 339 may be fitted with an optional radiopaque marker 341 to enhance visibility of the prosthesis under a fluoroscope. A space 342 is disposed between ends of locking tabs 332, defined by a narrow inlet portion 343 and a wider receiver portion 345 adapted to receive the rounded tip 337 on a locking tab 332 from an adjacent prosthesis 300. Locking tabs 332 on the opposite end of prosthesis 300 are circumferentially offset with respect to the first end so that adjacent prostheses may interleave and engage with one another. Fig. 3 B illustrates how the ends of prostheses 300 with locking tabs 332 engage one another.
[0058] Fig. 3C illustrates prosthesis 300 of Figs. 3A-3B in the expanded configuration and interlocked with an adjacent expanded prosthesis 300. In the expanded configuration, U- shaped connectors 322 deflect outwardly, expanding cells 326. Struts 320, while still
substantially straight, are no longer horizontal and thus the period of the sinusoidal-like wave pattern forming each cell 326 has increased and become more angular to form more of a zigzag, thereby increasing the diameter of the prosthesis. Cells 326 which originally appear as a series of horizontally oriented ovals, now appear as a series of triangles or diamonds. Sigmoidal connectors 328 maintain the spacing 330 between columns of cells 318.
Additionally, locking tabs 332 remain coupled between adjacent prostheses 300 even after expansion. Fig. 3D highlights the coupling of locking tabs 332 between adjacent prostheses 300 after expansion.
[0059] Fig. 4A illustrates another embodiment of a prosthesis 400 in the unexpanded configuration, unrolled and flattened out for clarity. This embodiment is similar to the embodiment in Figs. 3A-3D with the major difference being that this embodiment has fewer columns of open cells and different interlocking tabs on either end of the prosthesis.
[0060] Fig. 4A shows a preferred embodiment of a prosthesis illustrated in the unexpanded configuration, unrolled and flattened out for clarity. Prosthesis 400 comprises nine substantially parallel columns of 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426, spaced apart by a gap 430 and formed around a central axis 424 so that prosthesis 400 has a tubular or cylindrical shape. Each column 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i is formed from an undulating or sinusoidal or zig-zag or wave pattern 418. The wave pattern 418 is comprised of substantially axial struts 420 joined together by a U-shaped connector 422. The struts 420 are generally parallel to the central axis 424.
[0061] In this embodiment, each wave pattern 418 repeats itself sixteen times in each of the nine parallel columns 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426, although this number is not intended to be limiting. The number of rows of cells 426 may be increased to provide increased scaffolding of the lumen wall or the number of rows may be decreased to minimize the amount of metal in the prosthesis which contacts the lumen wall. The wave pattern 418 in each column is out-of-phase with the adjacent column, therefore the peak of one wave pattern 418 is adjacent to the trough of a wave 418 pattern in an adjacent column. In addition, the parallel columns 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426 are joined together by a sigmoidal shaped connector 428 which joins the ends of U-shaped connector 422 together.
[0062] The sigmoidal connector 428 generally attaches to the apex of the U-shaped connector 422. Also, the sigmoidal shaped connector 428 attaches generally to every fourth U-shaped connector 422, in each column 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i, thus there are four sigmoidal shaped connectors 428 between each column 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i of open cells 426. Additionally, the slope of the sigmoidal shaped connectors 428 generally slopes downward between columns 402a, 402b, 402c, 403d, 402e, 402f, 402g, 402h and 402i open cells 426. For example, the sigmoidal shaped connector 428 between column 402a and 402b is attached to U-shaped connector 422 in column 402a at a point generally at the apex of the U-shaped connector 422 and substantially parallel to the axial struts 420. The sigmoidal connector 428 slopes downward toward the adjacent U-shaped connector 422 in adjacent column 402b and attaches to the adjacent U-shaped connector 422 at a point generally at the apex of U-shaped connector 422 and substantially parallel to the axial struts 420. The sigmoidal shaped connector 422 between columns 402b and 402c similarly joins U-shaped connectors 422, sloping downward. This pattern repeats across the prosthesis 400 so that there are eight sets of sigmoidal shaped connectors 428 with downward slopes. Additionally, sigmoidal shaped connectors 422 are staggered such that across any row of open cells 426, a sigmoidal shaped connector 422 couples columns of open cells 426 every fourth gap 330. [0063] Both ends of prosthesis 400 comprise interlocking tabs. One end of prosthesis 400 has a locking male tab 432 and the opposite end has a female receiving tab 436. Male tab
432 has a wider head portion 434 defined by arcuate strut 438 unconnected at one end so that it may flex and a narrow neck portion 433 defined by axial strut 436. Axial struts 436 couple the male locking tab 432 to adjacent U-shaped connectors 422 and therefore there also is a spacing 442 between axial struts 436. Female receiving tab 436 also has an enlarged head portion 444 and a narrower neck portion 446. The head portion 444 is formed from arcuate struts 448 shaped like a "C" or a "U," and having bulbous tips 450. The arcuate struts 448 form a receptacle 454 which is adapted to interlock with the enlarged head portion 434 of male locking tab 432. The neck portion is formed from a wide strut 452 which joins with adjacent axial struts 420, replacing the U-shaped connector 422. Female tabs 436 are staggered relative to male tabs 432 so that adjacent prostheses may interlock with each other. Fig. 4B illustrates how the ends of prostheses 400 with tabs 432 and 436 engage one another.
[0064] Fig. 5 A shows another embodiment of an interlocking prosthesis 500 in the unexpanded configuration, unrolled and flattened out for clarity. This embodiment is similar
to that shown in Figs. 4A-4B with the major difference being the interlocking tabs on either end of the prosthesis 500. The overall geometry of prosthesis 500 is the same as prosthesis 400 above. For example, prosthesis 500 also has nine substantially parallel columns 502a, 502b, 502c, 502d, 502e, 502f, 502g, 502h and 502i of open cells 526 spaced apart by a gap 530 and formed around a central axis 524 so that prosthesis 500 has a tubular or cylindrical shape. Each column 502a, 502b, 502c, 502d, 502e, 502f, 502g, 502h and 502i has the same undulating wave pattern 418 as prosthesis 400 with a sigmoidal connector 528 coupling the nine columns 502a, 502b, 502c, 502d, 502e, 502f, 502g, 502h and 502i together. Other aspects of the sigmoidal connector 528 are generally the same as sigmoidal connector 428 described above with respect to Figs. 4A-4B.
[0065] Both ends of prosthesis 500 comprise interlocking tabs. One end of prosthesis 500 has a locking male tab 532 and the opposite end has a female receiving tab 536. Male tab 532 has a wider head portion 534 defined by an arcuate strut 538 forming a "C" shape and having free ends 539 that may flex, and a narrow neck portion 533 defined by an axial strut 536. The axial strut 536 is coupled with the C-shaped arcuate strut 538 approximately at the center of the concave portion of the "C." The axial strut 536 couples the male locking tab 532 to the prosthesis 500 at the apex of U-shaped connector 522 in open cell 526. There are four male locking tabs 532 on one end of prosthesis 500, spaced apart every four rows of open cells 526.
[0066] The opposite end of prosthesis 500 has a female receiving tab 536 which includes an enlarged head portion 544 and a narrower neck portion 546. The head portion 544 is formed from an arcuate strut 548 shaped like a "C" or a "U," and having enlarged tips 550 defining a receptacle 551 therein. An optional radiopaque marker 553 may be press-fit, welded or bonded into receptacle 551. Radiopaque markers are commonly fabricated from gold, platinum, iridium or tantalum. The arcuate strut 548 forms another receptacle 554 having a narrow inlet portion 560 and a wider receiver portion 562 which is adapted to interlock with the enlarged head portion 534 of male locking tab 532. The neck portion 546 is formed from a strut 552 which joins with the adjacent axial struts 520 which form open cells 526. Strut 552 joins with strut 520 at the apex of U-shaped connector 522. Female receiving tabs 536 are staggered with respect to male tabs 532 so that adjacent prostheses 500 may interlock with each other. Prostheses 500 interlock with one another by pressing them together. Fig. 5B illustrates how the ends of prostheses 500 with tabs 532 and 536 engage one another.
[0067] Other interleaving stent embodiments are described in copending U.S. Patent Application No. 10/738,666 filed December 16, 2003 (Attorney Docket No. 021629- 00051 OUS); U.S. Patent Application No. 10/957,079 filed September 30, 2004 (Attorney Docket No. 021629-00271 OUS); and U.S. Provisional Application No. 60/784,309 filed March 20, 2006 (Attorney Docket No. 021629-003600US), the entire contents of which are incorporated herein by reference.
[0068] Prostheses 128 are preferably composed of an elastic or superelastic shape memory alloy such as Nitinol so that the prostheses 128 resiliently self-expand upon release into a vessel by retraction of the sheath 124. Other possible materials include a spring temper metal such as stainless steel, cobalt-chromium or ELGILO Y™ so the prostheses 128 may self- expand in the body lumen at the target treatment site. In the case of self-expanding prostheses 128, an inflation balloon is not required but may still be used for predilation of a lesion or augmenting expansion of the self-expanding stent segments 128 (e.g. postdilation or tacking). Other materials such as biocompatible polymers may be used to fabricate prosthetic stent segments that self-expand, and these materials may further include bioabsorbable or bioerodable properties.
[0069] In other embodiments, prostheses 128 may have any of a variety of common constructions, such as but not limited to those described in U.S. Patent Application Serial No. 10/738,666 filed December 16, 2003 (Attorney Docket No. 02169-00051 OUS), which was previously incorporated by reference. Constructions may include for example, closed cell constructions including expansible ovals, ellipses, box structures, expandable diamond structures, etc. In addition, the closed cells may have complex slotted geometries such as H- shaped slots, I-shaped slots, J-shaped slots, etc. Suitable open cell structures include zig-zag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Patent Nos.: 6,315,794; 5,980,552; 5,836,964; 5,527,354; 5,421,955; 4,886,062; and 4,776,337.
[0070] In preferred embodiments, prosthetic stent segments 128 may be coated, impregnated, infused or otherwise coupled with one or more drugs that inhibit restenosis, such as Rapamycin, Everolimus, Biolimus A9, Paclitaxel, analogs, prodrugs, or derivatives of the aforementioned, or other suitable agents, preferably carried in a durable or bioerodable
carrier of polymeric or other suitable material. Alternatively, stent segments 128 may be coated with other types of drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, antiinflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics, endothelial cell attractors or promoters and/or stem cells. Such materials may be coated over all or a portion of the surface of stent segments 128, or stent segments 128 may have a porous structure or include apertures, holes, channels, or other features in which such materials may be deposited.
[0071] Referring now to Figs. 2A-2E, the deployment of selected prostheses to treat a lesion is shown in accordance with an exemplary embodiment. While the embodiment will be described in the context of a femoral artery stent procedure, it should be understood that the invention may be employed in any variety of coronary or peripheral arteries, blood vessels and other body lumens in which stents or tubular prostheses are deployed, including the carotid and iliac arteries, other arteries or veins, as well as non-vascular body lumens such as the ureter, urethra, fallopian tubes, the hepatic and biliary duct and the like. The delivery catheter is introduced into a treatment vessel first, by placing an introducer sheath (not illustrated) into the target peripheral artery, typically using a percutaneous procedure such as the Seldinger technique or by surgical cutdown. In this exemplary embodiment, the target vessel is a femoral artery. The introducer sheath is then advanced slightly into the femoral artery. A guidewire 138 is then inserted through the introducer and advanced into the target vessel V where a lesion L to be treated is located. The proximal end of guidewire 138 is then inserted through distal port 156 of nosecone 138 and through inner lumen 135 of inner shaft 134, exiting handle 106 at adapter 108 which is outside the patient's body. Optionally, a guide catheter may also be employed.
[0072] Fig. 2A shows a stent delivery catheter 200 slidably advanced over the guidewire 138 into the vessel V so that nosecone 138 is distal to lesion L. Self-expanding tubular prostheses 128 having ends spaced apart are disposed over inner shaft 134 and constrained by outer sheath 124. In this embodiment, four prostheses 128 are carried by the stent delivery catheter 200, although this is not intended to be limiting. The number of prostheses may be varied to accommodate different lesion lengths.
[0073] Outer sheath 124 has a high hoop strength near the distal end such that the outer sheath 124 is able to prevent the self-expanding prostheses 128 from expanding when the
outer sheath 124 is disposed thereover. This may be accomplished by using an outer sheath 124 with a suitable wall thickness or the sheath 124 may also have a distal portion formed from a metal or polymer reinforced with a metallic or polymeric braid to resist radial expansion of the self-expanding prostheses 128.
[0074] In this embodiment, each prosthesis 128 has a length approximately 20 mm long. Thus the delivery catheter 200 is adapted to deliver a prosthesis having a total length from about 20 mm long, up to 80 mm long, in 20 mm increments. Other lengths and quantities of prostheses 128 may be employed and this exemplary embodiment is not meant to limit the scope of the present invention.
[0075] Radiopaque marker 152 is disposed near the proximal end of nosecone 138 or alternatively, radiopaque marker 152 may be disposed on inner shaft 134 near the proximal end of nosecone 138. Radiopaque marker 153 is disposed near the distal end of pusher 144. Radiopaque markers are typically fabricated from gold, platinum, iridium or tantalum and are well known in the art. Radiopaque markers 152 and 153 help an operator to visualize the tip of delivery catheter 200 under fluoroscopy as well as determining the number of prostheses 128 to deploy to traverse the lesion L. In some embodiments, an optional radiopaque marker 151 may be disposed near the distal end of outer sheath 124 so that sheath position may also be observed under fluoroscopy. Pusher tube 144 is also seen in Fig. 2 A disposed over inner shaft 134. The distal end pusher tube 144 comprise several resilient fingers 166 which radially extend outward such that pusher tube 144 may be retracted proximally past prostheses 128 but when pusher 144 is advanced distally, the resilient fingers 166 engage a prosthesis 128 so that the prosthesis 128 is advanced distally as the pusher 144 is advanced. Distal motion of prosthesis 128 allows adjacent prostheses 128 having interlocking tabs 162 to engage with receptacle 164, eliminating gap 160. Pusher tube 144 also serves as a backstop to prevent proximal motion of prostheses 128. Additional details on these elements will be discussed in greater detail below, with respect to Figs. 2B-2E.
[0076] Referring now to Fig. 2B, the lesion L to be treated is typically visualized by introducing contrast media into the target vessel V and observing the resulting image under a fluoroscope. Radiopaque markers 152, 153 and optional radiopaque marker 151 are used to help visualized the position of the delivery catheter 200 relative to the lesion L as well as to visualize the length of prostheses 129 selected for deployment relative to the target lesion L. Radiopaque marker 152 is typically disposed near the proximal end of nosecone 136 but in
alternative embodiments marker 152 may also be disposed on the inner shaft 134 near the proximal end of nosecone 136. Delivery catheter 200 is advanced until radiopaque marker 152 is near the distal edge of lesion L. Pusher 144 will later be retracted proximally until it is near the proximal end of lesion L. The lesion therefore traverses the region between radiopaque markers 152 and 153. An optional radiopaque marker 151 disposed near the distal end of outer sheath 124 allows the user to observed sheath position during the stenting procedure.
[0077] In Fig. 2B, pusher tube 144 is retracted proximally until radiopaque marker 153 is near the proximal edge of lesion L. The distal end 166 pusher tube 144 comprises a plurality of resilient, radially extending inclined fingers 166, thus pusher tube 144 may be retracted proximally under prostheses 128 without displacing them. Retracting pusher 144 selects the number of prostheses 129 to be deployed and that will provide a total prosthesis 126 length that traverses the length of lesion L. Pusher 144 tube extends to the proximal end of delivery catheter 200 and retraction of pusher tube 144 is accomplished using a control mechanism such as slider 140 in Figs. IA or 1C.
[0078] In Fig. 2C, prostheses 129 are advanced distally until they engage and interlock with one another. Pusher tube 144 is advanced distally until it engages the proximal -most end of the proximal prosthesis 129 selected for delivery. The distal end of pusher tube 144 has resilient and radially extending inclined fingers 166. Advancing pusher tube 144 distally causes the fingers 166 to engage with the proximal-most prosthesis 129 selected for delivery. Further advancement of pusher tube 144 advances the selected prostheses 129 until the distal- most prosthesis 129 of those selected butts up against the proximal end of nose cone 136. Nosecone 136 has a recessed region 145 in which interlocking tab 162 may be received so that the distal-most prosthesis 129 can fit flush against nosecone 136. As pusher tube 144 is advanced, prostheses 129 selected for deployment bunch up together until locking tabs 162 engage and interlock with receivers 164 on an adjacent prosthesis 129. The gap 160 that existed between prostheses 128 prior to deployment therefore is reduced significantly to a slight gap or no gap 161 as prosthesis 129 ends are engaged with one another during deployment. Additionally, if after pushing prostheses 129 together, a longer total length is required, the steps illustrated in Figs. 2B-2C may be repeated in order to create a longer "stent train."
[0079] In Fig. 2D, the constraint covering prostheses 129 selected for deployment is removed. In Fig. 2D, outer sheath 124 is retracted proximally. Retraction of outer sheath 124 is accomplished using a control mechanism such as slider 102 in Figs. IA or 1C. Retracting outer sheath 124 removes the constraint and exposes prostheses 129, allowing them to self-expand into lesion L. As outer sheath 124 is retracted, the exposed portion of prostheses 129 self-expand to a final shape 137 matching lesion L. Prosthesis 129 is prevented from jumping or "watermelon seeding" away from delivery catheter 200 because the prosthesis 129 being deployed is interlocked with an adjacent prosthesis 129 maintained in the delivery catheter 200 and constrained by outer sheath 124. The position of the outer sheath 124 may be monitored by the operator by visualizing an optional radiopaque marker 151 on the distal end of outer sheath 124, or the operator may determine sheath position by observing the position of slider 102. Pusher tube 144 also serves as a backstop to prevent proximal displacement of prostheses 129 that might occur as a result of outer sheath 124 passing distally thereover.
[0080] In Fig. 2E, outer sheath 124 is retracted proximally until all prostheses 129 selected for deployment are unconstrained and they self-expand into the lesion L. If an additional prosthesis 128 is required to treat the lesion L, the pusher tube 144 may be retracted proximally so as to select an additional prosthesis 128 and it may be deployed in similar manner to that previously described. Once all prostheses 129 have been deployed, outer sheath 124 may be advanced distally until it engages nosecone 136 and the entire delivery catheter 200 may be removed from the treatment site. Alternatively, inner shaft 134 may be retracted into outer sheath 124 until nosecone 136 engages outer sheath 124 and then the entire delivery catheter 200 may be withdrawn.
[0081] While the exemplary embodiments have been described in some detail for clarity of understanding and by way of example, a variety of additional modifications, adaptations and changes may be clear to those of skill in the art. Hence, the scope of the present invention is limited solely by the appended claims.
Claims
WHAT IS CLAIMED IS:
L A catheter for delivering a prosthesis to a treatment site in a body lumen, the catheter comprising: an elongate flexible member having a proximal end and a distal end; a sheath slidably disposed over the elongate flexible member; a plurality of self-expanding tubular prostheses carried in axially spaced-apart locations along the elongate flexible member and within the sheath, the plurality of self- expanding tubular prostheses adapted to be selectively interlocked with one another and constrained by the sheath in a radially contracted configuration, the prostheses being separately releasable from the sheath as the sheath is retracted relative to the elongate flexible member; and a pusher member slidably disposed along the elongate flexible member within the sheath, the pusher member adapted to move past the prostheses in a first direction, while in a second direction the pusher member engages a selected prosthesis so as to move the prosthesis with the pusher member to interlock the selected prosthesis with a second prosthesis.
2. The catheter of claim 1 , further comprising a stopping element axially disposed along the elongate flexible member, the stopping element adapted to prevent the plurality of self-expanding tubular prostheses from being displaced past the distal end of the elongate flexible member when the pusher member is advanced distally.
3. The catheter of claim 1 , further comprising a handle near the proximal end of the elongate flexible member and having a control mechanism adapted to move the sheath and pusher member.
4. The catheter of claim 1 , wherein the pusher member is adapted to move past the prostheses in a first direction without displacement thereof.
5. The catheter of claim 1 , wherein the pusher member is slidable through the prostheses and comprises a plurality of fingers projecting radially outwardly so as to slide past the prostheses in a first direction while in a second direction the fingers engage the selected prosthesis.
6. The catheter of claim 1 , wherein the pusher member has an engagement member which is deflectable radially inward by contact with the prostheses when moved in the first direction.
7. The catheter of claim 6, wherein the engagement member comprises a plurality of flexible fingers extending radially outward from the pusher member.
8. The catheter of claim 1 , wherein the pusher member exerts substantially greater axial force against the plurality of self-expanding tubular prostheses when the pusher member is advanced distally than when the pusher member is retracted proximally.
9. The catheter of claim 1, further comprising a central lumen disposed within the elongate shaft and adapted to carry a guidewire.
10. The catheter of claim 1 , wherein the plurality of self-expanding tubular prostheses carry a therapeutic agent adapted to be released therefrom.
11. The catheter of claim 10, wherein the therapeutic agent comprises an anti-restenosis agent.
12. The catheter of claim 1 , wherein the plurality of self-expanding tubular prostheses have a length in the range of about 5 mm to about 50 mm.
13. The catheter of claim 1 , wherein each of the plurality of tubular self- expanding prostheses has the same length.
14. The catheter of claim 1 , wherein at least one of the plurality of self- expanding tubular prostheses has a different length than at least another of the prostheses.
15. The catheter of claim 1 , wherein the prostheses are adapted to be interlocked with one another when pressed together.
16. The catheter of claim 15, wherein the prostheses are adapted to remain interlocked with one another after radially expanding.
17. The catheter of claim 1 , wherein the prostheses comprise a plurality of substantially parallel columns of open cells, the columns spaced apart and formed from a zig- zag pattern of substantially axial struts joined together with a connector.
18. The catheter of claim 17, wherein a plurality of bridges join the columns of open cells together.
19. The catheter of claim 18, wherein the bridges are sigmoidally shaped.
20. The catheter of claim 1 , wherein the prostheses comprise an interlocking tab disposed on a first end of the prostheses and adapted to interlock with an adjacent prosthesis.
21. The catheter of claim 20, wherein the interlocking tab comprises an enlarged head region and a narrower neck region.
22. The catheter of claim 21 , wherein the enlarged head region comprises an arcuate strut defining a narrow inlet portion and a wider receiving portion, the receiving portion adapted to receive and interlock with an interlocking tab on an adjacent prosthesis.
23. The catheter of claim 21 , wherein the enlarged head is C-shaped.
24. The catheter of claim 20, wherein the interlocking tab comprises a strut defining an aperture.
25. The catheter of claim 24, wherein the aperture is adapted to hold a radiopaque marker.
26. The catheter of claim 21 , wherein the enlarged head comprises a plurality of arcuate struts coupled to the prosthesis with a plurality of axial struts.
27. The catheter of claim 21 , wherein the neck comprises a plurality of axial struts.
28. The catheter of claim 21 , wherein the enlarged head comprises an arcuate strut forming a C-shape coupled to the prosthesis with an axial strut.
29. The catheter of claim 1 , wherein the prostheses further comprise a female receiving tab on an opposite end of the prosthesis as the interlocking tab.
30. The catheter of claim 29, wherein the female tab comprises an arcuate strut defining a receptacle, the receptacle adapted to receive and interlock with an enlarged head of an adjacent prosthesis and wherein the arcuate strut is coupled to the prostheses with an axial strut.
31. The catheter of claim 30, wherein the receptacle is C-shaped.
32. The catheter of claim 29, wherein the female tab comprises an arcuate strut defining an aperture, the aperture adapted to hold a radiopaque marker.
33. The catheter of claim 17, wherein the connector comprises a U-shaped portion.
34. The catheter of claim 17, wherein the open cells in a first column are out of phase with the open cells in an adjacent column.
35. A method for delivering a prosthesis to a body lumen, the method comprising: introducing into the body lumen one or more self-expanding tubular prostheses carried at axially spaced apart locations along an elongate flexible member and constrained in a contracted configuration within a sheath, the body lumen having a lesion with a lesion length; selecting a first group of the self-expanding tubular prostheses for delivery, the first group having a combined length that substantially traverses the lesion length; bringing the first group into engagement with each other within the sheath so that prostheses in the first group interlock with one another; and uncovering the first group from the sheath so that they are unconstrained from expansion, wherein the first group expands at the first treatment site.
36. The method of claim 35, wherein the first group expands at the first treatment site while at least a second group of prostheses is retained within the sheath.
37. The method of claim 35, further comprising: selecting one or more additional self-expanding tubular prostheses; and bringing the additional self-expanding tubular prostheses into engagement with the first group within the sheath so that the additional prostheses interlock with the first group.
38. The method of claim 35, wherein selecting a first group comprises proximally retracting a pusher member.
39. The method of claim 35, wherein the pusher member has a flexible engagement member that is deflected by the prostheses as the pusher member is retracted proximally.
40. The method of claim 35, wherein bringing the first group into engagement with each other comprises engaging at least one of the first group of prostheses with a pusher member and advancing the pusher member distally.
41. The method of claim 35, wherein engaging the at least one prosthesis comprises engaging the prosthesis with a flexible engagement member disposed on the pusher member.
42. The method of claim 35, wherein bringing the first group into engagement with each other comprises stopping the first group of prostheses from moving distally with a stopping element disposed on the elongate flexible member.
43. The method of claim 35, wherein uncovering the first group comprises proximally retracting the sheath.
44. The method of claim 35, further comprising releasing a therapeutic agent from the first group after expansion at the treatment site.
45. The method of claim 44, wherein the therapeutic agent comprises an anti-restenosis agent.
46. The method of claim 35, wherein the plurality of self-expanding tubular prostheses have a length in the range of about 5 mm to about 50 mm.
47. The method of claim 35, wherein each of the plurality of self- expanding tubular prostheses has the same length.
48. The method of claim 35, wherein at least one of the plurality of self- expanding tubular prostheses has a different length than at least another of the prostheses.
49. The method of claim 35, wherein the prosthesis comprises a plurality of substantially parallel columns of open cells, the columns spaced apart and formed from a zig-zag pattern of substantially axial struts joined together with a connector.
50. The method of claim 35, wherein a plurality of bridges join the columns of open cells together.
51. The method of claim 50, wherein the bridges are sigmoidally shaped.
52. The method of claim 35, wherein a prosthesis comprises an interlocking tab disposed on a first end of the prosthesis and adapted to interlock with an adjacent prosthesis.
53. The method of claim 52, wherein the prosthesis comprises a mating tab disposed on a second end of the prosthesis opposite the first end, the mating tab adapted to interlock with an interlocking tab on an adjacent prosthesis.
54. The method of claim 52, wherein the interlocking tab comprises one or more struts defining an aperture therein.
55. The method of claim 52, wherein the interlocking tab comprises a radiopaque marker.
56. The method of claim 49, wherein the connector comprises a U-shaped portion.
57. The method of claim 49, wherein the open cells in a first column are out of phase with the open cells in an adjacent column.
58. A self-expanding tubular prosthesis comprising: a plurality of self-expanding tubular rings having a plurality of axial struts and a plurality of connectors coupling adjacent struts together, the axial struts and connectors forming a substantially zig-zag pattern; a bridge member coupling adjacent tubular rings together; and an interlocking tab on one end of the prosthesis coupled to a tubular ring, the interlocking tab adapted to interlock with an adjacent prosthesis when the prostheses are pressed together and wherein adjacent prostheses remain interlocked after they have self- expanded.
59. The prosthesis of claim 58, wherein the connectors are substantially U- shaped.
60. The prosthesis of claim 58, wherein the bridge member is sigmoidal- shaped.
61. The prosthesis of claim 58, wherein the bridge is coupled to a connector.
62. The prosthesis of claim 58, wherein the bridge comprises an axially extending strut that joins the bridge with the connector.
63. The prosthesis of claim 58, wherein the bridge connects to an apex of the connector.
64. The prosthesis of claim 58, wherein the interlocking tab comprises an enlarged head region and a narrower neck region.
65. The prosthesis of claim 64, wherein the enlarged head region comprises an arcuate strut defining a narrow inlet portion and a wider receiving portion, the receiving portion adapted to receive and interlock with an interlocking tab on an adjacent ring.
66. The prosthesis of claim 64, wherein the enlarged head is C-shaped.
67. The prosthesis of claim 58, wherein the interlocking tab comprises a strut defining an aperture, the aperture adapted to hold a radiopaque marker.
68. The prosthesis of claim 64, wherein the enlarged head region comprises a plurality of arcuate struts coupled to the prosthesis with a plurality of axial struts.
69. The prosthesis of claim 64, wherein the neck region comprises a plurality of axial struts.
70. The prosthesis of claim 64, wherein the enlarged head region comprises an arcuate strut forming a C-shape coupled to the prosthesis with an axial strut.
71. The prosthesis of claim 58, further comprising a female receiving tab on an end of the prosthesis opposite of the interlocking tab.
72. The prosthesis of claim 71, wherein the female tab comprises an arcuate strut defining a receptacle, the receptacle adapted to receive and interlock with an enlarged head of an adjacent prosthesis and wherein the arcuate strut is coupled to the prosthesis with an axial strut.
73. The prosthesis of claim 72, wherein the receptacle is C-shaped.
74. The prosthesis of claim 71 , wherein the female tab comprises an arcuate strut defining an aperture, the aperture adapted to hold a radiopaque marker.
75. The prosthesis of claim 58, further comprising a therapeutic agent carried on the prosthesis and adapted to be released therefrom.
76. The prosthesis of claim 75, wherein the therapeutic agent comprises an anti-restenosis agent.
77. The prosthesis of claim 58, wherein the prosthesis has an overall length in the range from about 5 mm to about 50 mm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010501071A JP2010522063A (en) | 2007-03-22 | 2008-03-17 | Device and method for controlling an expandable prosthesis during deployment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/689,927 US8486132B2 (en) | 2007-03-22 | 2007-03-22 | Devices and methods for controlling expandable prostheses during deployment |
US11/689,927 | 2007-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008118670A2 true WO2008118670A2 (en) | 2008-10-02 |
WO2008118670A3 WO2008118670A3 (en) | 2008-12-18 |
Family
ID=39775542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/057202 WO2008118670A2 (en) | 2007-03-22 | 2008-03-17 | Devices and methods for controlling expandable prostheses during deployment |
Country Status (3)
Country | Link |
---|---|
US (2) | US8486132B2 (en) |
JP (1) | JP2010522063A (en) |
WO (1) | WO2008118670A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3238669A1 (en) * | 2010-11-17 | 2017-11-01 | Boston Scientific Scimed, Inc. | Stent delivery systems |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
US8080048B2 (en) * | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US6866679B2 (en) | 2002-03-12 | 2005-03-15 | Ev3 Inc. | Everting stent and stent delivery system |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US7553324B2 (en) * | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
WO2007109621A2 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
US8652192B2 (en) * | 2006-03-31 | 2014-02-18 | St. Jude Medical, Cardiology Division, Inc. | Stent and system and method for deploying a stent |
US20070281117A1 (en) * | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
EP2083767B1 (en) | 2006-10-22 | 2019-04-03 | IDEV Technologies, INC. | Devices for stent advancement |
KR101297043B1 (en) | 2006-10-22 | 2013-08-14 | 이데브 테크놀로지스, 아이엔씨. | Methods for securing strand ends and the resulting devices |
US20080199510A1 (en) * | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20080255653A1 (en) * | 2007-04-13 | 2008-10-16 | Medtronic Vascular, Inc. | Multiple Stent Delivery System and Method |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US8926680B2 (en) * | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
US8940003B2 (en) | 2008-02-22 | 2015-01-27 | Covidien Lp | Methods and apparatus for flow restoration |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
EP2271390A4 (en) | 2008-04-11 | 2016-07-20 | Covidien Lp | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US8114151B2 (en) * | 2008-05-08 | 2012-02-14 | Boston Scientific Scimed, Inc. | Stent with tabs and holes for drug delivery |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
US8769796B2 (en) | 2008-09-25 | 2014-07-08 | Advanced Bifurcation Systems, Inc. | Selective stent crimping |
CN102215780B (en) | 2008-09-25 | 2015-10-14 | 高级分支系统股份有限公司 | Part crimped stent |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
GB2469296B (en) * | 2009-04-07 | 2011-03-09 | Cook Inc | Modular stent assembly |
CN103037816B (en) | 2010-03-24 | 2018-12-28 | 高级分支系统股份有限公司 | System and method for handling furcation |
WO2011119883A1 (en) | 2010-03-24 | 2011-09-29 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
AU2011232360B2 (en) | 2010-03-24 | 2015-10-08 | Advanced Bifurcation Systems Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
RU2564085C2 (en) * | 2011-01-14 | 2015-09-27 | Айдев Текнолоджиз, Инк. | Stent delivery system with plunger assembly |
WO2012109382A2 (en) | 2011-02-08 | 2012-08-16 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
EP2672932B1 (en) | 2011-02-08 | 2018-09-19 | Advanced Bifurcation Systems, Inc. | System for treating a bifurcation with a fully crimped stent |
DK2775968T3 (en) * | 2011-11-11 | 2017-12-18 | Medigroup Gmbh | Device for implanting stent elements in a hollow member |
US20130226278A1 (en) | 2012-02-23 | 2013-08-29 | Tyco Healthcare Group Lp | Methods and apparatus for luminal stenting |
US9072624B2 (en) | 2012-02-23 | 2015-07-07 | Covidien Lp | Luminal stenting |
US9254212B2 (en) * | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
US9078659B2 (en) | 2012-04-23 | 2015-07-14 | Covidien Lp | Delivery system with hooks for resheathability |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
US9724222B2 (en) * | 2012-07-20 | 2017-08-08 | Covidien Lp | Resheathable stent delivery system |
US10130500B2 (en) | 2013-07-25 | 2018-11-20 | Covidien Lp | Methods and apparatus for luminal stenting |
US9782186B2 (en) | 2013-08-27 | 2017-10-10 | Covidien Lp | Vascular intervention system |
US8968383B1 (en) | 2013-08-27 | 2015-03-03 | Covidien Lp | Delivery of medical devices |
US9943628B2 (en) * | 2014-07-30 | 2018-04-17 | Medtronic Vascular Inc. | Welded stent with radiopaque material localized at the welds and methods |
US20180000619A1 (en) * | 2015-01-29 | 2018-01-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375336B1 (en) * | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US20160242943A1 (en) | 2015-02-20 | 2016-08-25 | Cook Medical Technologies Llc | Duet stent deployment system and method of performing a transjugular intrahepatic portosystemic shunting procedure using same |
US10350067B2 (en) * | 2015-10-26 | 2019-07-16 | Edwards Lifesciences Corporation | Implant delivery capsule |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10022255B2 (en) | 2016-04-11 | 2018-07-17 | Idev Technologies, Inc. | Stent delivery system having anisotropic sheath |
US10588745B2 (en) * | 2016-06-20 | 2020-03-17 | Medtronic Vascular, Inc. | Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis |
CN106473850B (en) * | 2016-11-02 | 2018-05-01 | 尹先哲 | Complexity esophageal stricture particle stenter to implant device |
US10297059B2 (en) | 2016-12-21 | 2019-05-21 | Motorola Solutions, Inc. | Method and image processor for sending a combined image to human versus machine consumers |
US10376396B2 (en) | 2017-01-19 | 2019-08-13 | Covidien Lp | Coupling units for medical device delivery systems |
US10842654B2 (en) * | 2017-07-19 | 2020-11-24 | Cook Medical Technologies Llc | Stent with segments capable of uncoupling during expansion |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
EP3658083A4 (en) * | 2017-07-26 | 2021-08-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
CN108309521B (en) * | 2018-02-11 | 2024-04-12 | 郑州大学第一附属医院 | Thrombus-preventing bracket device of ascites hepatic vein diversion controllable one-way valve |
US11413176B2 (en) | 2018-04-12 | 2022-08-16 | Covidien Lp | Medical device delivery |
US11071637B2 (en) | 2018-04-12 | 2021-07-27 | Covidien Lp | Medical device delivery |
US10786377B2 (en) | 2018-04-12 | 2020-09-29 | Covidien Lp | Medical device delivery |
US11123209B2 (en) | 2018-04-12 | 2021-09-21 | Covidien Lp | Medical device delivery |
CN109350322B (en) * | 2018-12-06 | 2024-03-22 | 南京法迈特科技发展有限公司 | Double-bracket implantation device |
US11413174B2 (en) | 2019-06-26 | 2022-08-16 | Covidien Lp | Core assembly for medical device delivery systems |
US11944558B2 (en) | 2021-08-05 | 2024-04-02 | Covidien Lp | Medical device delivery devices, systems, and methods |
US20230092775A1 (en) * | 2021-09-20 | 2023-03-23 | Prodeon Medical Corporation | Delivery and deployment of a prostatic implant |
DE102022111893A1 (en) | 2022-05-12 | 2023-11-16 | Acandis Gmbh | Medical device for intravascular treatment and method of manufacturing |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030163085A1 (en) * | 2002-01-16 | 2003-08-28 | Tanner Howard M. | Catheter hand-piece apparatus and method of using the same |
US6858034B1 (en) * | 1999-05-20 | 2005-02-22 | Scimed Life Systems, Inc. | Stent delivery system for prevention of kinking, and method of loading and using same |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
Family Cites Families (461)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069825A (en) | 1976-01-28 | 1978-01-24 | Taichiro Akiyama | Surgical thread and cutting apparatus for the same |
US4564014A (en) | 1980-01-30 | 1986-01-14 | Thomas J. Fogarty | Variable length dilatation catheter apparatus and method |
US4468224A (en) | 1982-01-28 | 1984-08-28 | Advanced Cardiovascular Systems, Inc. | System and method for catheter placement in blood vessels of a human patient |
US4512338A (en) | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US5693083A (en) | 1983-12-09 | 1997-12-02 | Endovascular Technologies, Inc. | Thoracic graft and delivery catheter |
US4891225A (en) | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
DE3442736A1 (en) | 1984-11-23 | 1986-06-05 | Tassilo Dr.med. 7800 Freiburg Bonzel | DILATATION CATHETER |
US4690684A (en) | 1985-07-12 | 1987-09-01 | C. R. Bard, Inc. | Meltable stent for anastomosis |
US4770176A (en) | 1985-07-12 | 1988-09-13 | C. R. Bard, Inc. | Vessel anastomosis using meltable stent |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4681110A (en) | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
US4775337A (en) | 1986-12-02 | 1988-10-04 | Universal Manufacturing Corporation | Conductive wire with integral electrical terminal |
US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
US4988356A (en) | 1987-02-27 | 1991-01-29 | C. R. Bard, Inc. | Catheter and guidewire exchange system |
EP0282143B1 (en) | 1987-02-27 | 1993-09-15 | C.R. Bard, Inc. | Catheter and guidewire exchange system |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5171222A (en) | 1988-03-10 | 1992-12-15 | Scimed Life Systems, Inc. | Interlocking peel-away dilation catheter |
US4994298A (en) | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US6730105B2 (en) | 1988-07-29 | 2004-05-04 | Samuel Shiber | Clover leaf shaped tubular medical device |
US5226913A (en) | 1988-09-01 | 1993-07-13 | Corvita Corporation | Method of making a radially expandable prosthesis |
US5092877A (en) | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
US4994066A (en) | 1988-10-07 | 1991-02-19 | Voss Gene A | Prostatic stent |
US4994069A (en) | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US4950227A (en) | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
DE8916283U1 (en) | 1989-01-30 | 1997-05-15 | Bard Inc C R | Quickly replaceable coronary catheter |
US5217495A (en) | 1989-05-10 | 1993-06-08 | United States Surgical Corporation | Synthetic semiabsorbable composite yarn |
US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5158548A (en) | 1990-04-25 | 1992-10-27 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5013318A (en) | 1990-07-31 | 1991-05-07 | Special Devices Incorporated | Medical instrument for measuring depth of fastener hold in bone |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
AR246020A1 (en) | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
DE9117152U1 (en) | 1990-10-09 | 1996-07-11 | Cook Inc | Stent |
CA2060067A1 (en) | 1991-01-28 | 1992-07-29 | Lilip Lau | Stent delivery system |
US5533968A (en) | 1991-05-15 | 1996-07-09 | Advanced Cardiovascular Systems, Inc. | Low profile catheter with expandable outer tubular member |
US5135535A (en) | 1991-06-11 | 1992-08-04 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US5527354A (en) | 1991-06-28 | 1996-06-18 | Cook Incorporated | Stent formed of half-round wire |
US5490837A (en) | 1991-07-05 | 1996-02-13 | Scimed Life Systems, Inc. | Single operator exchange catheter having a distal catheter shaft section |
US5976107A (en) | 1991-07-05 | 1999-11-02 | Scimed Life Systems. Inc. | Catheter having extendable guide wire lumen |
ATE112847T1 (en) | 1991-07-29 | 1994-10-15 | Brandes Bernd | EQUIPMENT AND PROCEDURE FOR DETECTING LEAKS IN TUBES FOR LIQUID MEDIA. |
US5443498A (en) | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5456713A (en) | 1991-10-25 | 1995-10-10 | Cook Incorporated | Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5628775A (en) | 1991-11-08 | 1997-05-13 | Ep Technologies, Inc. | Flexible bond for sleeves enclosing a bendable electrode tip assembly |
US5192297A (en) | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
DE69330119T2 (en) | 1992-01-09 | 2001-08-02 | Advanced Cardiovascular System | DEVICE FOR REPLACING A GUIDE WIRE |
US5261887A (en) | 1992-01-22 | 1993-11-16 | Baxter International Inc. | Easy-to-handle, self-guiding catheter stripper |
US5246421A (en) | 1992-02-12 | 1993-09-21 | Saab Mark A | Method of treating obstructed regions of bodily passages |
US5282823A (en) | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5273536A (en) | 1992-04-02 | 1993-12-28 | Vicky Savas | Tapered balloon catheter |
US5201757A (en) | 1992-04-03 | 1993-04-13 | Schneider (Usa) Inc. | Medial region deployment of radially self-expanding stents |
US5507771A (en) | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5562725A (en) | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US5312415A (en) | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
ES2089342T3 (en) | 1992-10-31 | 1996-10-01 | Schneider Europ Ag | DISPOSITION OF INTRODUCTION OF A SELF-EXPANDING ENDOPROTESIS. |
US5336178A (en) | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
CA2149887A1 (en) | 1992-12-30 | 1994-07-21 | Steven J. Healy | Apparatus for deploying body implantable stents |
US5328469A (en) | 1993-03-19 | 1994-07-12 | Roger Coletti | Hybrid balloon angioplasty catheter and methods of use |
US5607463A (en) | 1993-03-30 | 1997-03-04 | Medtronic, Inc. | Intravascular medical device |
JPH08509642A (en) | 1993-04-28 | 1996-10-15 | フォーカル,インコーポレイテッド | Device and method for intraluminal photothermoforming |
US5549553A (en) | 1993-04-29 | 1996-08-27 | Scimed Life Systems, Inc. | Dilation ballon for a single operator exchange intravascular catheter or similar device |
US5480423A (en) | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5334187A (en) | 1993-05-21 | 1994-08-02 | Cathco, Inc. | Balloon catheter system with slit opening handle |
US5391172A (en) | 1993-05-24 | 1995-02-21 | Advanced Cardiovascular Systems, Inc. | Stent delivery system with coaxial catheter handle |
SE506110C2 (en) | 1993-06-01 | 1997-11-10 | Hudiksvalls Teknik Ct Ab | Device dedicated to making holes in golf greens |
US5458615A (en) | 1993-07-06 | 1995-10-17 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US5735892A (en) | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5545209A (en) | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US5989280A (en) | 1993-10-22 | 1999-11-23 | Scimed Lifesystems, Inc | Stent delivery apparatus and method |
US5445646A (en) | 1993-10-22 | 1995-08-29 | Scimed Lifesystems, Inc. | Single layer hydraulic sheath stent delivery apparatus and method |
US5607444A (en) | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
US5549635A (en) | 1994-01-24 | 1996-08-27 | Solar, Rita & Gaterud, Ltd. | Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore |
US6051020A (en) | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
DE69514690T3 (en) | 1994-02-25 | 2006-09-14 | Fischell, Robert E. | stent |
US5453090A (en) | 1994-03-01 | 1995-09-26 | Cordis Corporation | Method of stent delivery through an elongate softenable sheath |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
CA2261941C (en) | 1994-04-01 | 2005-06-21 | Prograft Medical, Inc. | Self-expandable stent and stent-graft and method of using them |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
US5478349A (en) | 1994-04-28 | 1995-12-26 | Boston Scientific Corporation | Placement of endoprostheses and stents |
JP3647456B2 (en) | 1994-04-29 | 2005-05-11 | ボストン・サイエンティフィック・コーポレーション | Medical artificial stent and method for producing the same |
DE69527141T2 (en) | 1994-04-29 | 2002-11-07 | Scimed Life Systems Inc | STENT WITH COLLAGEN |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
US5456694A (en) | 1994-05-13 | 1995-10-10 | Stentco, Inc. | Device for delivering and deploying intraluminal devices |
US5514093A (en) | 1994-05-19 | 1996-05-07 | Scimed Life Systems, Inc. | Variable length balloon dilatation catheter |
DE4418336A1 (en) | 1994-05-26 | 1995-11-30 | Angiomed Ag | Stent for widening and holding open receptacles |
US5683451A (en) | 1994-06-08 | 1997-11-04 | Cardiovascular Concepts, Inc. | Apparatus and methods for deployment release of intraluminal prostheses |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US5636641A (en) | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
US5575816A (en) | 1994-08-12 | 1996-11-19 | Meadox Medicals, Inc. | High strength and high density intraluminal wire stent |
US5723003A (en) | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5470315A (en) | 1994-09-20 | 1995-11-28 | Scimed Life Systems, Inc. | Over-the-wire type balloon catheter with proximal hypotube |
US5702419A (en) | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
US5531735A (en) | 1994-09-27 | 1996-07-02 | Hercules Incorporated | Medical devices containing triggerable disintegration agents |
US5549563A (en) | 1994-10-11 | 1996-08-27 | Kronner; Richard F. | Reinforcing insert for uterine manipulator |
US5522882A (en) | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
CA2163823A1 (en) | 1994-11-28 | 1996-05-29 | Richard S. Stack | System and method for delivering multiple stents |
US5735869A (en) | 1994-11-30 | 1998-04-07 | Schneider (Europe) A.G. | Balloon catheter and stent delivery device |
US5628755A (en) | 1995-02-20 | 1997-05-13 | Schneider (Europe) A.G. | Balloon catheter and stent delivery system |
CA2163708C (en) | 1994-12-07 | 2007-08-07 | Robert E. Fischell | Integrated dual-function catheter system for balloon angioplasty and stent delivery |
US5549551A (en) | 1994-12-22 | 1996-08-27 | Advanced Cardiovascular Systems, Inc. | Adjustable length balloon catheter |
US5662675A (en) | 1995-02-24 | 1997-09-02 | Intervascular, Inc. | Delivery catheter assembly |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
DE69637527D1 (en) | 1995-03-01 | 2008-06-26 | Boston Scient Scimed Inc | Longitudinally flexible and expandable stent |
US5709713A (en) | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
WO1996032078A1 (en) | 1995-04-14 | 1996-10-17 | Schneider (Usa) Inc. | Rolling membrane stent delivery device |
US5807398A (en) | 1995-04-28 | 1998-09-15 | Shaknovich; Alexander | Shuttle stent delivery catheter |
FR2733682B1 (en) | 1995-05-04 | 1997-10-31 | Dibie Alain | ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR |
US5534007A (en) | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
US5681347A (en) | 1995-05-23 | 1997-10-28 | Boston Scientific Corporation | Vena cava filter delivery system |
JPH10503411A (en) | 1995-05-25 | 1998-03-31 | メドトロニック・インコーポレーテッド | Stent assembly and method of using the same |
US5639274A (en) | 1995-06-02 | 1997-06-17 | Fischell; Robert E. | Integrated catheter system for balloon angioplasty and stent delivery |
CA2223399C (en) | 1995-06-06 | 2003-08-05 | Corvita Corporation | Endovascular measuring apparatus, loading and deployment means |
US7611533B2 (en) | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US6010530A (en) | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
AU5776696A (en) | 1995-06-08 | 1997-01-09 | Bard Galway Limited | Bifurcated endovascular stent |
JP3467916B2 (en) | 1995-07-10 | 2003-11-17 | 松下電器産業株式会社 | Transmission / reception method |
US5877224A (en) | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
US5797951A (en) | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
US5776141A (en) | 1995-08-28 | 1998-07-07 | Localmed, Inc. | Method and apparatus for intraluminal prosthesis delivery |
DE19531659C2 (en) | 1995-08-29 | 1998-07-02 | Ernst Peter Prof Dr M Strecker | Stent |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
WO1999037242A1 (en) | 1998-01-26 | 1999-07-29 | Anson Medical Limited | Reinforced graft |
US5702418A (en) | 1995-09-12 | 1997-12-30 | Boston Scientific Corporation | Stent delivery system |
US5868704A (en) | 1995-09-18 | 1999-02-09 | W. L. Gore & Associates, Inc. | Balloon catheter device |
JPH11511363A (en) | 1995-09-18 | 1999-10-05 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | Intraluminal vascular graft delivery device |
JP3725919B2 (en) | 1995-09-26 | 2005-12-14 | キーパー株式会社 | Resin CVJ boots |
US5591195A (en) | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
US5749848A (en) | 1995-11-13 | 1998-05-12 | Cardiovascular Imaging Systems, Inc. | Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment |
US5755697A (en) | 1995-11-22 | 1998-05-26 | Jones; Calvin E. | Self-tunneling, self-securing percutaneous catheterization device and method of use thereof |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US6090063A (en) | 1995-12-01 | 2000-07-18 | C. R. Bard, Inc. | Device, system and method for implantation of filaments and particles in the body |
US6579305B1 (en) | 1995-12-07 | 2003-06-17 | Medtronic Ave, Inc. | Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material |
US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
US6878161B2 (en) | 1996-01-05 | 2005-04-12 | Medtronic Vascular, Inc. | Stent graft loading and deployment device and method |
US5895398A (en) | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US5749921A (en) | 1996-02-20 | 1998-05-12 | Medtronic, Inc. | Apparatus and methods for compression of endoluminal prostheses |
DE69729137T2 (en) | 1996-03-10 | 2005-05-12 | Terumo K.K. | Stent for implantation |
US6334871B1 (en) | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
US6533805B1 (en) | 1996-04-01 | 2003-03-18 | General Surgical Innovations, Inc. | Prosthesis and method for deployment within a body lumen |
US6783543B2 (en) | 2000-06-05 | 2004-08-31 | Scimed Life Systems, Inc. | Intravascular stent with increasing coating retaining capacity |
US5670161A (en) | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US5709701A (en) | 1996-05-30 | 1998-01-20 | Parodi; Juan C. | Apparatus for implanting a prothesis within a body passageway |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
US7238197B2 (en) | 2000-05-30 | 2007-07-03 | Devax, Inc. | Endoprosthesis deployment system for treating vascular bifurcations |
FR2749500B1 (en) | 1996-06-06 | 1998-11-20 | Jacques Seguin | DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION |
US6666883B1 (en) | 1996-06-06 | 2003-12-23 | Jacques Seguin | Endoprosthesis for vascular bifurcation |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US6190402B1 (en) | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
EP0820784B1 (en) | 1996-07-24 | 2003-06-11 | Cordis Corporation | Balloon catheter and methods of use |
US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
DE19630469C2 (en) | 1996-07-27 | 2000-12-21 | Michael Betzler | Vascular endoprosthesis, especially for the endovascular treatment of aortic aneurysms |
US6090136A (en) | 1996-07-29 | 2000-07-18 | Radiance Medical Systems, Inc. | Self expandable tubular support |
US5922020A (en) | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US6217585B1 (en) | 1996-08-16 | 2001-04-17 | Converge Medical, Inc. | Mechanical stent and graft delivery system |
US6007517A (en) | 1996-08-19 | 1999-12-28 | Anderson; R. David | Rapid exchange/perfusion angioplasty catheter |
US6007543A (en) | 1996-08-23 | 1999-12-28 | Scimed Life Systems, Inc. | Stent delivery system with stent securement means |
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
JP3968444B2 (en) | 1996-08-23 | 2007-08-29 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Stent delivery mechanism with stent fixation device |
US20030093143A1 (en) | 1999-03-01 | 2003-05-15 | Yiju Zhao | Medical device having surface depressions containing nitric oxide releasing compound |
US5921971A (en) | 1996-09-13 | 1999-07-13 | Boston Scientific Corporation | Single operator exchange biliary catheter |
US6254628B1 (en) | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
US5772669A (en) | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US5755776A (en) | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US6086610A (en) | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US5843119A (en) | 1996-10-23 | 1998-12-01 | United States Surgical Corporation | Apparatus and method for dilatation of a body lumen and delivery of a prothesis therein |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7220275B2 (en) | 1996-11-04 | 2007-05-22 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US5843090A (en) | 1996-11-05 | 1998-12-01 | Schneider (Usa) Inc. | Stent delivery device |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
EP0843990B1 (en) | 1996-11-15 | 2003-07-30 | Schneider (Europe) GmbH | Balloon catheter and delivery device for a stent |
US5749890A (en) | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US5858556A (en) | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
JP3523765B2 (en) | 1997-01-24 | 2004-04-26 | テルモ株式会社 | Living organ dilator |
AU746009B2 (en) | 1997-01-24 | 2002-04-11 | Celonova Stent, Inc | Bistable spring construction for a stent and other medical apparatus |
US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
GB9703859D0 (en) | 1997-02-25 | 1997-04-16 | Plante Sylvain | Expandable intravascular stent |
US5814064A (en) | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
US6035856A (en) | 1997-03-06 | 2000-03-14 | Scimed Life Systems | Percutaneous bypass with branching vessel |
IL128261A0 (en) | 1999-01-27 | 1999-11-30 | Disc O Tech Medical Tech Ltd | Expandable element |
US6344272B1 (en) | 1997-03-12 | 2002-02-05 | Wm. Marsh Rice University | Metal nanoshells |
US6852252B2 (en) | 1997-03-12 | 2005-02-08 | William Marsh Rice University | Use of metalnanoshells to impede the photo-oxidation of conjugated polymer |
US5817101A (en) | 1997-03-13 | 1998-10-06 | Schneider (Usa) Inc | Fluid actuated stent delivery system |
US5792144A (en) | 1997-03-31 | 1998-08-11 | Cathco, Inc. | Stent delivery catheter system |
US8172897B2 (en) | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
US5843172A (en) | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6143016A (en) | 1997-04-21 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Sheath and method of use for a stent delivery system |
US5965879A (en) | 1997-05-07 | 1999-10-12 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method and apparatus for ultra-high-sensitivity, incremental and absolute optical encoding |
EP0884063B1 (en) | 1997-06-10 | 2004-04-28 | Schneider ( Europe) GmbH | Catheter system |
US6004328A (en) | 1997-06-19 | 1999-12-21 | Solar; Ronald J. | Radially expandable intraluminal stent and delivery catheter therefore and method of using the same |
FR2764794B1 (en) | 1997-06-20 | 1999-11-12 | Nycomed Lab Sa | EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS |
DE19728337A1 (en) | 1997-07-03 | 1999-01-07 | Inst Mikrotechnik Mainz Gmbh | Implantable stent |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6070589A (en) | 1997-08-01 | 2000-06-06 | Teramed, Inc. | Methods for deploying bypass graft stents |
US5899935A (en) | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US5984957A (en) | 1997-08-12 | 1999-11-16 | Schneider (Usa) Inc | Radially expanded prostheses with axial diameter control |
US6306166B1 (en) | 1997-08-13 | 2001-10-23 | Scimed Life Systems, Inc. | Loading and release of water-insoluble drugs |
US6056722A (en) | 1997-09-18 | 2000-05-02 | Iowa-India Investments Company Limited Of Douglas | Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use |
US6231598B1 (en) | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
US5972027A (en) | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US5961536A (en) | 1997-10-14 | 1999-10-05 | Scimed Life Systems, Inc. | Catheter having a variable length balloon and method of using the same |
US6511468B1 (en) | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
NO311781B1 (en) | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
US6027519A (en) | 1997-12-15 | 2000-02-22 | Stanford; Ulf Harry | Catheter with expandable multiband segment |
US6022374A (en) | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6050999A (en) | 1997-12-18 | 2000-04-18 | Keravision, Inc. | Corneal implant introducer and method of use |
US6159178A (en) | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
US6280467B1 (en) | 1998-02-26 | 2001-08-28 | World Medical Manufacturing Corporation | Delivery system for deployment and endovascular assembly of a multi-stage stented graft |
US6428811B1 (en) | 1998-03-11 | 2002-08-06 | Wm. Marsh Rice University | Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
US6699724B1 (en) | 1998-03-11 | 2004-03-02 | Wm. Marsh Rice University | Metal nanoshells for biosensing applications |
US6425898B1 (en) | 1998-03-13 | 2002-07-30 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US7491232B2 (en) | 1998-09-18 | 2009-02-17 | Aptus Endosystems, Inc. | Catheter-based fastener implantation apparatus and methods with implantation force resolution |
US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
EP0943300A1 (en) | 1998-03-17 | 1999-09-22 | Medicorp S.A. | Reversible action endoprosthesis delivery device. |
US6558415B2 (en) | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
US6132460A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6102942A (en) | 1998-03-30 | 2000-08-15 | Endovascular Technologies, Inc. | Stent/graft deployment catheter with a stent/graft attachment mechanism |
US6063111A (en) | 1998-03-31 | 2000-05-16 | Cordis Corporation | Stent aneurysm treatment system and method |
IE980241A1 (en) | 1998-04-02 | 1999-10-20 | Salviac Ltd | Delivery catheter with split sheath |
US6037647A (en) | 1998-05-08 | 2000-03-14 | Fujitsu Limited | Semiconductor device having an epitaxial substrate and a fabrication process thereof |
EP1083960A4 (en) | 1998-05-15 | 2001-09-12 | Medgination Inc | Enhanced balloon dilatation system |
US6036725A (en) | 1998-06-10 | 2000-03-14 | General Science And Technology | Expandable endovascular support device |
US6171334B1 (en) | 1998-06-17 | 2001-01-09 | Advanced Cardiovascular Systems, Inc. | Expandable stent and method of use |
DE19829702C1 (en) | 1998-07-03 | 2000-03-16 | Heraeus Gmbh W C | Radially expandable support device V |
WO2000012832A2 (en) | 1998-08-26 | 2000-03-09 | Molecular Geodesics, Inc. | Radially expandable device |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
WO2000015151A1 (en) | 1998-09-16 | 2000-03-23 | Isostent, Inc. | Linkage stent |
US5997563A (en) | 1998-09-28 | 1999-12-07 | Medtronic, Inc. | Implantable stent having variable diameter |
US6196995B1 (en) | 1998-09-30 | 2001-03-06 | Medtronic Ave, Inc. | Reinforced edge exchange catheter |
US6254612B1 (en) | 1998-10-22 | 2001-07-03 | Cordis Neurovascular, Inc. | Hydraulic stent deployment system |
US6293967B1 (en) | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
DE19855421C2 (en) | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implant |
US6214036B1 (en) | 1998-11-09 | 2001-04-10 | Cordis Corporation | Stent which is easily recaptured and repositioned within the body |
SG75982A1 (en) | 1998-12-03 | 2000-10-24 | Medinol Ltd | Controlled detachment stents |
US6340366B2 (en) | 1998-12-08 | 2002-01-22 | Bandula Wijay | Stent with nested or overlapping rings |
US6187034B1 (en) | 1999-01-13 | 2001-02-13 | John J. Frantzen | Segmented stent for flexible stent delivery system |
US6022359A (en) | 1999-01-13 | 2000-02-08 | Frantzen; John J. | Stent delivery system featuring a flexible balloon |
US6350277B1 (en) | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
US6558414B2 (en) | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
US6248122B1 (en) | 1999-02-26 | 2001-06-19 | Vascular Architects, Inc. | Catheter with controlled release endoluminal prosthesis |
WO2000049973A2 (en) | 1999-02-26 | 2000-08-31 | Vascular Architects, Inc. | Coiled stent and catheter assembly |
US6251134B1 (en) | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
US5976155A (en) | 1999-03-05 | 1999-11-02 | Advanced Cardiovascular Systems, Inc. | System for removably securing a stent on a catheter assembly and method of use |
US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6379365B1 (en) | 1999-03-29 | 2002-04-30 | Alexis Diaz | Stent delivery catheter system having grooved shaft |
US6258117B1 (en) | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6730116B1 (en) | 1999-04-16 | 2004-05-04 | Medtronic, Inc. | Medical device for intraluminal endovascular stenting |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6585756B1 (en) | 1999-05-14 | 2003-07-01 | Ernst P. Strecker | Implantable lumen prosthesis |
US6375676B1 (en) | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6290673B1 (en) | 1999-05-20 | 2001-09-18 | Conor Medsystems, Inc. | Expandable medical device delivery system and method |
US6241758B1 (en) | 1999-05-28 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent delivery system and method of use |
DE19938377A1 (en) | 1999-08-06 | 2001-03-01 | Biotronik Mess & Therapieg | Stent for vascular branching |
US6415696B1 (en) | 1999-09-01 | 2002-07-09 | Kennametal Pc Inc. | Toolholder assembly |
US6605062B1 (en) | 1999-09-02 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Catheter for guidewire support or exchange |
US6203551B1 (en) | 1999-10-04 | 2001-03-20 | Advanced Cardiovascular Systems, Inc. | Chamber for applying therapeutic substances to an implant device |
US6383171B1 (en) | 1999-10-12 | 2002-05-07 | Allan Will | Methods and devices for protecting a passageway in a body when advancing devices through the passageway |
AU1083101A (en) | 1999-10-12 | 2001-04-23 | Allan R. Will | Methods and devices for protecting a passageway in a body |
US6409753B1 (en) | 1999-10-26 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible stent |
US6325823B1 (en) | 1999-10-29 | 2001-12-04 | Revasc Corporation | Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use |
US6287291B1 (en) | 1999-11-09 | 2001-09-11 | Advanced Cardiovascular Systems, Inc. | Protective sheath for catheters |
US6428569B1 (en) | 1999-11-09 | 2002-08-06 | Scimed Life Systems Inc. | Micro structure stent configurations |
US6908624B2 (en) | 1999-12-23 | 2005-06-21 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
JP4473390B2 (en) | 2000-01-07 | 2010-06-02 | 川澄化学工業株式会社 | Stent and stent graft |
US6322586B1 (en) | 2000-01-10 | 2001-11-27 | Scimed Life Systems, Inc. | Catheter tip designs and method of manufacture |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
DE10003000A1 (en) | 2000-01-24 | 2001-08-02 | Deutsch Zentr Luft & Raumfahrt | Method for determining near-ground UV radiation |
US20010049547A1 (en) | 2000-02-04 | 2001-12-06 | Moore Scott T. | Stent introducer apparatus |
US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US7373197B2 (en) | 2000-03-03 | 2008-05-13 | Intramedical Imaging, Llc | Methods and devices to expand applications of intraoperative radiation probes |
EP1693000B1 (en) | 2000-03-08 | 2013-05-08 | Given Imaging Ltd. | A device for in vivo imaging |
DE10012460A1 (en) | 2000-03-15 | 2001-09-20 | Biotronik Mess & Therapieg | Stent consists of several adjacent lengthwise tubular sections joined by first and second connections consisting of cell-type elements of one orientation. |
US6264683B1 (en) | 2000-03-17 | 2001-07-24 | Advanced Cardiovascular Systems, Inc. | Stent delivery catheter with bumpers for improved retention of balloon expandable stents |
AUPQ641400A0 (en) | 2000-03-23 | 2000-04-15 | Kleiner, Daniel E. | A device incorporating a hollow member for being positioned along a body cavity of a patient and method of positioning same |
US6315708B1 (en) | 2000-03-31 | 2001-11-13 | Cordis Corporation | Stent with self-expanding end sections |
US6702843B1 (en) | 2000-04-12 | 2004-03-09 | Scimed Life Systems, Inc. | Stent delivery means with balloon retraction means |
US6964676B1 (en) | 2000-04-14 | 2005-11-15 | Scimed Life Systems, Inc. | Stent securement system |
US6451050B1 (en) | 2000-04-28 | 2002-09-17 | Cardiovasc, Inc. | Stent graft and method |
KR20030060771A (en) | 2000-04-28 | 2003-07-16 | 메모리얼 슬로안-케터링 캔서 센터 | Topical anesthetic/opioid formulations and uses thereof |
AU2001259429A1 (en) | 2000-05-02 | 2001-11-12 | Wilson-Cook Medical Inc. | Introducer device for catheters o.t.l. with eversible sleeve |
US6602282B1 (en) | 2000-05-04 | 2003-08-05 | Avantec Vascular Corporation | Flexible stent structure |
WO2001091918A1 (en) | 2000-05-31 | 2001-12-06 | Advanced Cardiovascular Systems, Inc. | An apparatus and method for forming a coating onto a surface of a prosthesis |
JP4754714B2 (en) | 2000-06-01 | 2011-08-24 | テルモ株式会社 | Intraluminal indwelling |
US6554848B2 (en) | 2000-06-02 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Marker device for rotationally orienting a stent delivery system prior to deploying a curved self-expanding stent |
US6569180B1 (en) | 2000-06-02 | 2003-05-27 | Avantec Vascular Corporation | Catheter having exchangeable balloon |
US6540775B1 (en) | 2000-06-30 | 2003-04-01 | Cordis Corporation | Ultraflexible open cell stent |
US6555157B1 (en) | 2000-07-25 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Method for coating an implantable device and system for performing the method |
US6773446B1 (en) | 2000-08-02 | 2004-08-10 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6629992B2 (en) | 2000-08-04 | 2003-10-07 | Advanced Cardiovascular Systems, Inc. | Sheath for self-expanding stent |
US6776771B2 (en) | 2000-09-14 | 2004-08-17 | Tuborg Engineering | Adaptive balloon with improved flexibility |
US6945989B1 (en) | 2000-09-18 | 2005-09-20 | Endotex Interventional Systems, Inc. | Apparatus for delivering endoluminal prostheses and methods of making and using them |
ATE384486T1 (en) | 2000-09-22 | 2008-02-15 | Boston Scient Ltd | FLEXIBLE AND EXPANDABLE STENT |
US6589273B1 (en) | 2000-10-02 | 2003-07-08 | Impra, Inc. | Apparatus and method for relining a blood vessel |
US6602226B1 (en) | 2000-10-12 | 2003-08-05 | Scimed Life Systems, Inc. | Low-profile stent delivery system and apparatus |
WO2002059226A2 (en) | 2000-11-03 | 2002-08-01 | Wm. Marsh Rice University | Partial coverage metal nanoshells and method of making same |
US6582394B1 (en) | 2000-11-14 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcated vessels |
US6743251B1 (en) | 2000-11-15 | 2004-06-01 | Scimed Life Systems, Inc. | Implantable devices with polymeric detachment junction |
US6607553B1 (en) | 2000-11-17 | 2003-08-19 | B. Braun Medical, Inc. | Method for deploying a thermo-mechanically expandable stent |
US6582460B1 (en) | 2000-11-20 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | System and method for accurately deploying a stent |
US6884257B1 (en) | 2000-11-28 | 2005-04-26 | Advanced Cardiovascular Systems, Inc. | Stent delivery system with adjustable length balloon |
US6565599B1 (en) | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
US6468298B1 (en) | 2000-12-28 | 2002-10-22 | Advanced Cardiovascular Systems, Inc. | Gripping delivery system for self-expanding stents and method of using the same |
US7208002B2 (en) | 2001-01-04 | 2007-04-24 | Boston Scientific Scimed, Inc. | Expansion-assisting delivery system for self-expanding stent |
DE10103000B4 (en) | 2001-01-24 | 2007-08-30 | Qualimed Innovative Medizinprodukte Gmbh | Radially re-expandable vascular support |
DE10105160B4 (en) | 2001-02-06 | 2005-09-01 | Osypka, Peter, Dr.-Ing. | Implantable vascular support |
US6540777B2 (en) | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
KR20090130879A (en) | 2001-02-16 | 2009-12-24 | 애보트 래보러토리즈 배스큘라 엔터프라이지즈 리미티드 | Implants with fk506 |
US7799064B2 (en) | 2001-02-26 | 2010-09-21 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
WO2002067653A2 (en) | 2001-02-26 | 2002-09-06 | Scimed Life Systems, Inc. | Bifurcated stent and delivery system |
US6790227B2 (en) | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US20020123786A1 (en) | 2001-03-02 | 2002-09-05 | Ventrica, Inc. | Methods and devices for bypassing an obstructed target vessel by placing the vessel in communication with a heart chamber containing blood |
CA2708607C (en) | 2001-03-13 | 2015-02-10 | Yoram Richter | Method and apparatus for stenting |
US6592549B2 (en) | 2001-03-14 | 2003-07-15 | Scimed Life Systems, Inc. | Rapid exchange stent delivery system and associated components |
EP1258230A3 (en) | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
US6660031B2 (en) | 2001-04-11 | 2003-12-09 | Scimed Life Systems, Inc. | Multi-length delivery system |
WO2002085253A1 (en) | 2001-04-20 | 2002-10-31 | The Board Of Trustees Of The Leland Stanford Junior University | Drug delivery platform and methods for the inhibition of neointima formation |
US6712845B2 (en) | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US6837901B2 (en) | 2001-04-27 | 2005-01-04 | Intek Technology L.L.C. | Methods for delivering, repositioning and/or retrieving self-expanding stents |
GB0110551D0 (en) | 2001-04-30 | 2001-06-20 | Angiomed Ag | Self-expanding stent delivery service |
EP1254644A1 (en) | 2001-05-01 | 2002-11-06 | Pan Medical Limited | Variable form stent and deployment arrangement for use therewith |
US6749628B1 (en) | 2001-05-17 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US8337540B2 (en) | 2001-05-17 | 2012-12-25 | Advanced Cardiovascular Systems, Inc. | Stent for treating bifurcations and method of use |
SE0101887L (en) | 2001-05-30 | 2002-12-01 | Jan Otto Solem | Vascular instrument and method |
US6562067B2 (en) | 2001-06-08 | 2003-05-13 | Cordis Corporation | Stent with interlocking elements |
US6676693B1 (en) | 2001-06-27 | 2004-01-13 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for delivering a self-expanding stent |
EP1277449B2 (en) | 2001-07-20 | 2012-07-11 | Sorin Biomedica Cardio S.R.L. | Stent |
US6599296B1 (en) | 2001-07-27 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Ratcheting handle for intraluminal catheter systems |
US6679909B2 (en) | 2001-07-31 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Rapid exchange delivery system for self-expanding stent |
JP4525958B2 (en) | 2001-08-27 | 2010-08-18 | 独立行政法人産業技術総合研究所 | Manufacturing method of semiconductor device |
US20030045923A1 (en) | 2001-08-31 | 2003-03-06 | Mehran Bashiri | Hybrid balloon expandable/self expanding stent |
SG108867A1 (en) | 2001-09-06 | 2005-02-28 | Medinol Ltd | Self articulating stent |
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
US20030055485A1 (en) | 2001-09-17 | 2003-03-20 | Intra Therapeutics, Inc. | Stent with offset cell geometry |
ATE519438T1 (en) | 2001-09-26 | 2011-08-15 | Rice University | OPTICALLY ABSORBING NANOPARTICLES FOR IMPROVED TISSUE REPAIR |
US6778316B2 (en) | 2001-10-24 | 2004-08-17 | William Marsh Rice University | Nanoparticle-based all-optical sensors |
JP4043216B2 (en) | 2001-10-30 | 2008-02-06 | オリンパス株式会社 | Stent |
US6939376B2 (en) | 2001-11-05 | 2005-09-06 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7682387B2 (en) | 2002-04-24 | 2010-03-23 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7014654B2 (en) | 2001-11-30 | 2006-03-21 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US8080048B2 (en) | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7270668B2 (en) | 2001-12-03 | 2007-09-18 | Xtent, Inc. | Apparatus and methods for delivering coiled prostheses |
US8353945B2 (en) | 2001-12-03 | 2013-01-15 | J.W. Medical System Ltd. | Delivery catheter having active engagement mechanism for prosthesis |
US20030114919A1 (en) | 2001-12-10 | 2003-06-19 | Mcquiston Jesse | Polymeric stent with metallic rings |
US6991646B2 (en) | 2001-12-18 | 2006-01-31 | Linvatec Biomaterials, Inc. | Method and apparatus for delivering a stent into a body lumen |
US20050182477A1 (en) | 2001-12-20 | 2005-08-18 | White Geoffrey H. | Intraluminal stent and graft |
US7537607B2 (en) | 2001-12-21 | 2009-05-26 | Boston Scientific Scimed, Inc. | Stent geometry for improved flexibility |
US6939368B2 (en) | 2002-01-17 | 2005-09-06 | Scimed Life Systems, Inc. | Delivery system for self expanding stents for use in bifurcated vessels |
US6981985B2 (en) | 2002-01-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Stent bumper struts |
US6911040B2 (en) | 2002-01-24 | 2005-06-28 | Cordis Corporation | Covered segmented stent |
US7029493B2 (en) | 2002-01-25 | 2006-04-18 | Cordis Corporation | Stent with enhanced crossability |
US7004964B2 (en) | 2002-02-22 | 2006-02-28 | Scimed Life Systems, Inc. | Apparatus and method for deployment of an endoluminal device |
US7887573B2 (en) | 2002-02-22 | 2011-02-15 | Boston Scientific Scimed, Inc. | Method and apparatus for deployment of an endoluminal device |
US6866679B2 (en) | 2002-03-12 | 2005-03-15 | Ev3 Inc. | Everting stent and stent delivery system |
GB0206061D0 (en) | 2002-03-14 | 2002-04-24 | Angiomed Ag | Metal structure compatible with MRI imaging, and method of manufacturing such a structure |
US6800065B2 (en) | 2002-04-04 | 2004-10-05 | Medtronic Ave, Inc. | Catheter and guide wire exchange system |
US7052511B2 (en) | 2002-04-04 | 2006-05-30 | Scimed Life Systems, Inc. | Delivery system and method for deployment of foreshortening endoluminal devices |
US20030195609A1 (en) | 2002-04-10 | 2003-10-16 | Scimed Life Systems, Inc. | Hybrid stent |
WO2003088848A2 (en) | 2002-04-16 | 2003-10-30 | Tyco Healthcare Group Lp | Method and apparatus for anastomosis including an expandable anchor |
US20040024450A1 (en) | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7470281B2 (en) | 2002-04-26 | 2008-12-30 | Medtronic Vascular, Inc. | Coated stent with crimpable coating |
US6645547B1 (en) | 2002-05-02 | 2003-11-11 | Labcoat Ltd. | Stent coating device |
AU2003243334A1 (en) | 2002-05-29 | 2003-12-19 | Cook Incorporated | Multi-piece prosthesis deployment apparatus |
US7056523B1 (en) | 2002-06-21 | 2006-06-06 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine |
US20040015224A1 (en) | 2002-07-22 | 2004-01-22 | Armstrong Joseph R. | Endoluminal expansion system |
US6761734B2 (en) | 2002-07-22 | 2004-07-13 | William S. Suhr | Segmented balloon catheter for stenting bifurcation lesions |
US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
US6945995B2 (en) | 2002-08-29 | 2005-09-20 | Boston Scientific Scimed, Inc. | Stent overlap point markers |
US8518096B2 (en) | 2002-09-03 | 2013-08-27 | Lifeshield Sciences Llc | Elephant trunk thoracic endograft and delivery system |
US6951053B2 (en) | 2002-09-04 | 2005-10-04 | Reva Medical, Inc. | Method of manufacturing a prosthesis |
US6893417B2 (en) | 2002-09-20 | 2005-05-17 | Medtronic Vascular, Inc. | Catheter and guide wire exchange system with improved proximal shaft and transition section |
JP4033747B2 (en) | 2002-09-30 | 2008-01-16 | テルモ株式会社 | Biological organ expansion device |
US7223283B2 (en) | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
US6994721B2 (en) | 2002-10-21 | 2006-02-07 | Israel Henry M | Stent assembly |
US7169172B2 (en) | 2002-11-01 | 2007-01-30 | Counter Clockwise, Inc. | Method and apparatus for caged stent delivery |
EP1562517B1 (en) | 2002-11-07 | 2010-06-16 | Abbott Laboratories | Prosthesis with multiple drugs in discrete unmixed droplets |
CA2513721C (en) | 2002-11-08 | 2013-04-16 | Conor Medsystems, Inc. | Method and apparatus for reducing tissue damage after ischemic injury |
ITRM20020596A1 (en) | 2002-11-27 | 2004-05-28 | Mauro Ferrari | IMPLANT VASCULAR PROSTHESIS WITH COMBINED, LAPAROSCOPIC AND ENDOVASCULAR TECHNIQUES, FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS, AND OPERATIONAL EQUIPMENT FOR THE RELEASE OF A PROSTHESIS EQUIPPED WITH ANCHORING STENTS. |
WO2004049978A1 (en) | 2002-12-04 | 2004-06-17 | Cook Incorporated | Method and device for treating aortic dissection |
EP1575454A4 (en) | 2002-12-09 | 2006-11-29 | Medtronic Vascular Inc | Modular stent having polymer bridges at modular unit contact sites |
US6849084B2 (en) | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
US7314480B2 (en) | 2003-02-27 | 2008-01-01 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery |
WO2004093746A1 (en) | 2003-03-26 | 2004-11-04 | The Foundry Inc. | Devices and methods for treatment of abdominal aortic aneurysm |
JP2006521161A (en) | 2003-03-26 | 2006-09-21 | カーディオマインド インコーポレイティッド | Implant delivery technology |
US7208001B2 (en) | 2003-04-24 | 2007-04-24 | Medtronic Vascular, Inc. | Catheter with detached proximal inflation and guidewire shafts |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US7131993B2 (en) | 2003-06-25 | 2006-11-07 | Boston Scientific Scimed, Inc. | Varying circumferential spanned connectors in a stent |
US7744620B2 (en) | 2003-07-18 | 2010-06-29 | Intervalve, Inc. | Valvuloplasty catheter |
US7281130B2 (en) * | 2003-07-30 | 2007-10-09 | Hewlett-Packard Development Company, L.P. | Storing authentication sequences for expedited login to secure applications |
US8784472B2 (en) | 2003-08-15 | 2014-07-22 | Boston Scientific Scimed, Inc. | Clutch driven stent delivery system |
US20050055077A1 (en) | 2003-09-05 | 2005-03-10 | Doron Marco | Very low profile medical device system having an adjustable balloon |
US20050209674A1 (en) | 2003-09-05 | 2005-09-22 | Kutscher Tuvia D | Balloon assembly (V) |
US20070219613A1 (en) | 2003-10-06 | 2007-09-20 | Xtent, Inc. | Apparatus and methods for interlocking stent segments |
US7553324B2 (en) | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US20050080475A1 (en) | 2003-10-14 | 2005-04-14 | Xtent, Inc. A Delaware Corporation | Stent delivery devices and methods |
US7192440B2 (en) | 2003-10-15 | 2007-03-20 | Xtent, Inc. | Implantable stent delivery devices and methods |
US7175654B2 (en) | 2003-10-16 | 2007-02-13 | Cordis Corporation | Stent design having stent segments which uncouple upon deployment |
US20050085897A1 (en) | 2003-10-17 | 2005-04-21 | Craig Bonsignore | Stent design having independent stent segments which uncouple upon deployment |
US20050123451A1 (en) | 2003-10-31 | 2005-06-09 | Hiroshi Nomura | System and apparatus for body fluid analysis using surface-textured optical materials |
US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
US7090694B1 (en) | 2003-11-19 | 2006-08-15 | Advanced Cardiovascular Systems, Inc. | Portal design for stent for treating bifurcated vessels |
US8157855B2 (en) | 2003-12-05 | 2012-04-17 | Boston Scientific Scimed, Inc. | Detachable segment stent |
US7244336B2 (en) | 2003-12-17 | 2007-07-17 | Lam Research Corporation | Temperature controlled hot edge ring assembly for reducing plasma reactor etch rate drift |
US20070156225A1 (en) | 2003-12-23 | 2007-07-05 | Xtent, Inc. | Automated control mechanisms and methods for custom length stent apparatus |
US9232948B2 (en) | 2003-12-23 | 2016-01-12 | Stryker Corporation | Catheter with distal occlusion apparatus |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US20050149168A1 (en) | 2003-12-30 | 2005-07-07 | Daniel Gregorich | Stent to be deployed on a bend |
GB0400571D0 (en) | 2004-01-12 | 2004-02-11 | Angiomed Gmbh & Co | Implant |
US20050171568A1 (en) | 2004-01-30 | 2005-08-04 | Niall Duffy | Catheter and guidewire exchange system with improved catheter design |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050222671A1 (en) | 2004-03-31 | 2005-10-06 | Schaeffer Darin G | Partially biodegradable stent |
US20050228477A1 (en) | 2004-04-09 | 2005-10-13 | Xtent, Inc. | Topographic coatings and coating methods for medical devices |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US20050278011A1 (en) | 2004-06-10 | 2005-12-15 | Peckham John E | Stent delivery system |
WO2006001367A1 (en) | 2004-06-25 | 2006-01-05 | Zeon Corporation | Stent |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
CA2571899A1 (en) | 2004-07-01 | 2006-08-03 | Yale University | Targeted and high density drug loaded polymeric materials |
CA2585219A1 (en) | 2004-10-25 | 2006-05-04 | Alveolus, Inc. | Stent removal and repositioning device and associated method |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
US7402168B2 (en) | 2005-04-11 | 2008-07-22 | Xtent, Inc. | Custom-length stent delivery system with independently operable expansion elements |
US8641746B2 (en) | 2005-05-31 | 2014-02-04 | J.W. Medical Systems Ltd. | In situ stent formation |
US7320702B2 (en) | 2005-06-08 | 2008-01-22 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses (III) |
US7938851B2 (en) | 2005-06-08 | 2011-05-10 | Xtent, Inc. | Devices and methods for operating and controlling interventional apparatus |
US8021426B2 (en) | 2005-06-15 | 2011-09-20 | Ouroboros Medical, Inc. | Mechanical apparatus and method for artificial disc replacement |
JP4797473B2 (en) | 2005-07-11 | 2011-10-19 | ニプロ株式会社 | Flexible stent with excellent expandability |
US20080249607A1 (en) | 2005-09-20 | 2008-10-09 | Thomas Jay Webster | Biocompatable Nanophase Materials |
US20070179587A1 (en) | 2006-01-30 | 2007-08-02 | Xtent, Inc. | Apparatus and methods for deployment of custom-length prostheses |
WO2007109621A2 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
US20070265637A1 (en) | 2006-04-21 | 2007-11-15 | Xtent, Inc. | Devices and methods for controlling and counting interventional elements |
US20070281117A1 (en) | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
EP2043567B1 (en) | 2006-06-30 | 2011-07-13 | Boston Scientific Limited | Stent design with variable expansion columns along circumference |
US20080269865A1 (en) | 2006-08-07 | 2008-10-30 | Xtent, Inc. | Custom Length Stent Apparatus |
FR2911063B1 (en) | 2007-01-09 | 2009-03-20 | Stentys S A S Soc Par Actions | RUPTIBLE BRIDGE STRUCTURE FOR STENT, AND STENT INCLUDING SUCH BRIDGE STRUCTURES. |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US9370642B2 (en) | 2007-06-29 | 2016-06-21 | J.W. Medical Systems Ltd. | Adjustable-length drug delivery balloon |
US20090076584A1 (en) | 2007-09-19 | 2009-03-19 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
-
2007
- 2007-03-22 US US11/689,927 patent/US8486132B2/en active Active
-
2008
- 2008-03-17 WO PCT/US2008/057202 patent/WO2008118670A2/en active Application Filing
- 2008-03-17 JP JP2010501071A patent/JP2010522063A/en active Pending
-
2013
- 2013-07-15 US US13/942,557 patent/US9339404B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858034B1 (en) * | 1999-05-20 | 2005-02-22 | Scimed Life Systems, Inc. | Stent delivery system for prevention of kinking, and method of loading and using same |
US20030163085A1 (en) * | 2002-01-16 | 2003-08-28 | Tanner Howard M. | Catheter hand-piece apparatus and method of using the same |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3238669A1 (en) * | 2010-11-17 | 2017-11-01 | Boston Scientific Scimed, Inc. | Stent delivery systems |
EP3238669B1 (en) | 2010-11-17 | 2020-11-04 | Boston Scientific Scimed, Inc. | Stent delivery systems |
Also Published As
Publication number | Publication date |
---|---|
US20140018899A1 (en) | 2014-01-16 |
JP2010522063A (en) | 2010-07-01 |
WO2008118670A3 (en) | 2008-12-18 |
US8486132B2 (en) | 2013-07-16 |
US9339404B2 (en) | 2016-05-17 |
US20080234795A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9339404B2 (en) | Devices and methods for controlling expandable prostheses during deployment | |
US9700448B2 (en) | Devices and methods for controlling expandable prostheses during deployment | |
US11439524B2 (en) | Apparatus and methods for deployment of multiple custom-length prostheses (III) | |
US8956398B2 (en) | Custom length stent apparatus | |
JP4671960B2 (en) | Apparatus and method for deploying an artificial blood vessel | |
US20080269865A1 (en) | Custom Length Stent Apparatus | |
US20070219613A1 (en) | Apparatus and methods for interlocking stent segments | |
US20070179587A1 (en) | Apparatus and methods for deployment of custom-length prostheses | |
US20090076584A1 (en) | Apparatus and methods for deployment of multiple custom-length prostheses | |
US20100241069A1 (en) | Ostial lesion stent delivery system | |
US11648139B2 (en) | Delivery systems for stents having protruding features |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08732333 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2010501071 Country of ref document: JP Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08732333 Country of ref document: EP Kind code of ref document: A2 |